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Abstract: Suppose, contrary to fact, in 1950, we had put the cohort of
18 year old non-smoking American men on a stringent mandatory diet that
guaranteed that no one would ever weigh more than their baseline weight estab-
lished at age 18. How would the counter-factual mortality of these 18 year olds
have compared to their actual observed mortality through 2007? We describe
in detail how this counterfactual contrast could be estimated from longitudinal
epidemiologic data similiar to that stored in the electronic medical records of a
large HMO by applying g-estimation to a novel structural nested model. Our
analytic approach differs from any alternative approach in that in that, in the
abscence of model misspecification, it can successfully adjust for (i) measured
time-varying confounders such as exercise, hypertension and diabetes that are
simultaneously intermediate variables on the causal pathway from weight gain to
death and determinants of future weight gain, (ii) unmeasured confounding by
undiagnosed preclinical disease (i.e reverse causation) that can cause both poor
weight gain and premature mortality [provided an upper bound can be specified
for the maximum length of time a subject may suffer from a subclinical illness
severe enough to affect his weight without the illness becomes clinically mani-
fest], and (iii) the prescence of particular identifiable subgroups, such as those
suffering from serious renal, liver, pulmonary, and/or cardiac disease, in whom
confounding by unmeasured prognostic factors so severe as to render useless any
attempt at direct analytic adjustment. However (ii) and (iii) limit the ability to
empirically test whether the structural nested model is misspecified. The other
two g-methods - parametric g-computation algorithm and inverse probability of
treatment weighted (IPTW) estimation of maginal structural models (MSMs)
can adjust for potential bias due to (i) but not due to (ii) or (iii).
Key words: BMI, confounders, G-estimation, reverse causation, structural
nested failure time model
1 Introduction
Suppose, contrary to fact, in 1950, we had put the cohort of 18 year old non-
smoking American men on a stringent mandatory diet that guaranteed that no
one would ever weigh more than their baseline weight established at age 18.
Specifically, each subject was weighed every day starting on the day before his
18th birthday. Whenever his weight was greater than or equal to this baseline
weight, the subject’s caloric intake was restricted, without changing his usual
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mix of calorie sources and micronutrients, until the time (usually within 1-3
days) that the subject fell to below baseline weight. (I restrict to men solely
to avoid the complicating issue of how much weight gain to allow during preg-
nancy.) Thus, ignoring errors of a pound or two, no subject would ever weigh
more than his baseline weight. No instructions or restrictions were given con-
cerning exercise at any time or the amount or nature of what the subject ate
during non-calorie restricted periods. How would the counter-factual mortality
of these 18 year olds have compared to the actual observed mortality through
2007.
Factually, a substantial fraction of 18 year old American male gains more
than 30 lbs from age 18 to 74. Thus if the counterfactual mortality were much
less than the observed mortality, then, it would make sense for individuals to
maintain their baseline body weight by restricting caloric intake (regardless of
whether or not a practical, non-mandatory public health intervention exists that
would successfully maintain the baseline weight of most of the (non-smoking)
US population.) Here and throught we use the phrase ” maintain their age
x bodyweight” to mean that after age x a subject’s weight never exceeds his
weight at age x, although it may drop below that weight.
The difference between the counterfactual mortality were no one to exceed
their age 18 body weight and the actual observed mortality of the non-smoking
US population has been discussed by Willett et al (1) as a useful way to con-
ceptualize the effect of weight on mortality. A major goal of this paper is to
show that g-estimation of a novel structural nested model (SNM) can be used to
directly estimate this difference from longitudinal observational data. A SNM
is a model that takes as input a subject’s observed outcome in their observed
exposure (here, weight) history, and an unknown parameter and outputs the re-
sponse that would have been observed if, contrary to fact, the subject to follow
the stringent mandatory diet described above. The unknown parameter vector
of a SNM is estimated via the g-estimation procedure introduced in Robins et al
(12). Previous analytic approaches to the estimation of the effect of weight on
mortality do not provide a direct estimate of this difference. In addition, previ-
ous approaches have suffered from one or more of the following sources of bias :
(i) failure to adequately control for measured confounding due to time-varying
exercise, blood lipids, blood pressure, diabetes, and other chronic diseases (once
diagnosed) because of concerns that one will thereby be controlling for inter-
mediate variables on the causal pathway from overweight to death, (ii) failure
to adequately control for unmeasured confounding due to undiagnosed chronic
disease such as cancer (i.e., reverse causation) and (iii) failure to update the
weight of a subject whose weight changes after start of follow-up, because of
concerns about reverse causation and measurement error.
Bias due to confounding by measured time-varying confounders that are
also intermediate variables can be controlled by the use so-called of g-methods.
G - methods are statistical methods specifically designed to control bias at-
tributable to time-varying confounders affected by previous exposure. In addi-
tion to g-estimation of structural nested models, g-methods include the paramet-
ric g-formula estimator and inverse probability of treatment weighted (IPTW)
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estimators (7,15). As yet g-methods have not been used to estimate the effect
of overweight on obesity with the exception of Ref. (2), where the parametric
g-formula estimator was used. In this paper we concentrate on g-estimation of
SNMs, because as discussed below, of the three g-methods, only g-estimation
of SNMs can adjust for unmeasured confounding due to undiagnosed chronic
disease.
Finally g-estimation of SNMs allows one to update the weight of a subject
whose weight changes after start of follow-up without introducing any bias due
to reverse causation. However issues of measurement error are more tricky and
will be discussed in the final section of the paper.
Even if maintenance of age 18 weight improves mortality, perhaps a manda-
tory intervention that allowed weight gain of 0.3/12 pounds per month (i.e.,
3 pounds per decade) would produce an even lower mortality. Perhaps the
mandatory intervention that would produce the lowest mortality ( i.e., the op-
timal intervention among all ”weight-gain” interventions) is one that allows a
weight gain of 0.3/12 pounds pounds per month in subjects free of hyperten-
sion, diabetes, hyperlipidemia, or clinical CHD, but of only 0.1/12 pounds per
two month (i.e., 1 pound per decade) once a subject developed one of these risk
factors.
To decide which mandatory intervention is optimal, we require a well-defined
numerical measure of overall mortality that can be used to rank interventions.
For example, one might use the total years of life (or quality adjusted life) expe-
rienced by the cohort from 1950-2007 as a measure. Use of this measure is math-
ematically equivalent to the use of ”years (or quality-adjusted years) of life lived
from 1950-2007” as the (subject -specific) utility function in a decision problem
whose goal is to maximize expected utility. ”Years (or quality-adjusted years)
of life lived” measures have a much more natural and useful public health and
policy interpretation than the rate ratio, attributable fraction, and attributable
risk measures routinely reported in epidemiologic studies.
However even ”years of life lived from 1950-2007” is an inadequate utility
function when follow-up of the cohort is not to extinction. This function inap-
propriately assigns the same utility not only to all subjects alive at age 74 on
Jan 1, 2008 regardless of their state of health, but also to a subject who dies
on Dec. 31, 2007 at 11:59 pm. Clearly among survivors in 2008, the healthier
ones (according to some agreed on standard measure of current health ) have
a greater post-study expected survival (and thus warrant a higher utility) than
the less healthy survivors and a much greater expected survival (and thus war-
rant a much higher utility) than the non-survivors who died in late December
2007. We will not discuss further precisely how to decide on an appropriate
utility measure for the survivors, except to remark that such a discussion is
necessary. Rather, we will simply assume that, at the end of follow-up, each
cohort member has been given a utility measure Y.
Note that the benefit of any of the above counterfactual interventions is an
overall effect of the intervention. For example it is conceivable that the mortality
benefit of the intervention that maintained baseline weight was wholly due to
changes in exercise. Perhaps maintenance of baseline weight makes individuals
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feel so much better that they exercise more.
In section 2, we assume we have observational retrospective follow-up data
through 2007 on a random sample of the cohort of US males who were non-
smokers and 18 in 1950. The data includes detailed medical records, analogous
to those currently available on subscribers to a comprehensive HMO. In Sec.
2.2, I discuss three major sources of potential bias that complicate any attempt
to estimate the overall effect of the mandatory intervention ”maintain base-
line weight” on the expected utility of our cohort: (i) measured time-varying
confounders such as exercise, hypertension and diabetes that are potentially
intermediate variables, (ii) unmeasured confounding by undiagnosed preclinical
disease (i.e reverse causation) that can cause both poor weight gain and pre-
mature mortality, and (iii) the prescence of particular identifiable subgroups,
such as those suffering from serious renal, liver, pulmonary, and/or cardiac dis-
ease, in whom confounding by unmeasured prognostic factors is so severe as to
render useless direct analytic adjustment for confounding. In Section 3, I de-
scribe how g-estimation of a correctly specified SNM can appropriately adjust
for these potential sources of bias, [provided an upper bound can be specified
for the maximum length of time a subject may suffer from a subclinical illness
severe enough to affect his weight before the illness becomes clinically manifest].
The SNM required for this adjustment is novel in two ways. First it is a joint
SNM, combining a structural nested failure time model (SNFTM) for the coun-
terfactual time to the earlier of death or the diagnosis of a chronic illness and a
conditional structural nested mean model (SNMM) for the counterfactual mean
of a subject’s counterfactual utility given his counterfactual time to death or a
diagnosed chronic illness. Second our SNM only models the causal effect of an
any increase in BMI between month m and m + 1 over a subject’s maximum
previous BMI. In particular, it does not model and thus is agnostic about the
causal effect a) of any decrease in BMI or b) of any increase in BMI between
m and m+1 that fails to attain the previous maximum. As a consequence, our
SNM is more robust than standard SNMs that also model a) and b), because
our model makes fewer asumptions than such alternative models, and thus is
less likely to be mispecified. However, the small number of assumptions made
by our SNM are sufficient to consistently estimate our parameter of interest
E [Y0] .
In Sections 3.2.4-3.2.5, however, I show that (ii) and (iii) limit the ability to
empirically test whether the joint structural nested model is misspecified. I also
show that, somewhat remarkably, to adjust for bias due to reverse causation one
need not assume a deterministic rank-preserving SNM. This is important since
a deterministing rank-preserving SNM assumes that the effect of weight-gain
on mortality is the same for different subjects, an assumption that is clearly
biologically implausible. In Section 4, I consider how to account for censoring
by administative end of follow-up. In Section 5, I consider the estimation of
the expected utility under alternative dietary interventions. In Section 6, I
discuss the consequences of measurement error in BMI. Proofs and statements
of several new theorems are collected in Appendices 1and 2. Finally, estimation
of the optimal ”weight-gain”intervention is discussed in the Appendix 3.
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2 Estimation of an overall effect
2.1 The Data
I first describe the observational data that is supposed to be available. First,
I suppose that a subject’s BMI is recorded at the end of each month t, t =
0, 1, ...,K, where time t is in months since age 18 andK+1 = (2007− 1950)×12
is the duration of follow-up. Let A∗(t) be the difference between BMI at the end
of month t and at the end of month t− 1. Let L (t) be the vector of covariates
values recorded in month t and suppose L (t) precedes A∗ (t) temporally. L(t)
includes blood pressure, HDL and LDL measures of cholesterol, any diagnoses
of and clinical and laboratory characteristics of any chronic disease such as can-
cer, CAD, diabetes, asthma, COPD, liver, renal disease, etc., level of exercise,
measures of mobility and disability, etc. The vector L (t) also includes BMI (t) ,
the BMI just before t rounded to the nearest pound. Thus
A∗ (t) = BMI (t+ 1)−BMI (t) . (1)
L (t) also includes the indicator I (T > t) of vital status at the beginning of
month t with T the death time of a subject and, for any proposition B, I (B) is
the indicator function that take the value 1 if B is true and zero otherwise Thus
I (T > t) = 1 if a subject is alive at t and zero if dead at t. If I (T > t) = 0, I
include in L (t) the exact day of death and, by convention, assign the value zero
to all other components of L (t).
By convention, set A∗ (t) and the remaining components of L (t) to zero once
a subject has died.
The baseline covariates L (0) include covariate and BMI data on a subject
before follow up starts at age 18. Specifically, let BMI (0) denote BMI at (just
before) age 18 (i.e., time 0). Our inclusion of BMI just before age 18 as a
covariate rather than a treatment reflects the fact that ”change” in BMI since
18 is our exposure. In particular, note that A∗ (0) is the difference between
BMI recorded just before 18 yrs and 1 month and BMI recorded just before
18 years. As is standard in the literature, I have taken change in BMI rather
than in change in weight in pounds as the exposure variable. Let A∗ (t) and
L (t) be change in BMI and covariate history through time t and A∗=A∗ (K)
be a subjects (change in) BMI history through month K and L=L (K + 1) be
L history through the end of the study. A subject’s utility Y, a measure of
quality-adjusted survival, is calculated from L=L (K + 1) since L includes the
survival time of nonsurvivors, health status measures for survivors at end of
follow-up, and time-varying health status factors.
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2.2 Potential for Measured and Unmeasured Confound-
ing:
2.2.1 Reverse Causation and Unmeasured Confounding by Subclin-
ical Disease:
In the literature on the effect of BMI on mortality, a controversy has arisen as
whether and how to modify standard analytic methods to account for ”reverse
causation”. Reverse causation refers to the well-accepted fact that preclinical
(i.e., undiagnosed) chronic disease, such as preclinical cancer, can cause both
weight loss (or diminished weight gain) and death. It follows that among sub-
jects with identical BMI history
(
A∗ (t− 1) , BMI (0)
)
and measured covariate
history L (t) before age t, the subset whose monthly change A∗ (t) in BMI is
negative are not comparable with regard to mortality risk to the subset with
positive A∗ (t) , even if BMI has no causal effect on mortality. That is, reverse
causation implies unmeasured confounding by undiagnosed chronic disease. In
fact, by an analogous argument, even among the subset with A∗ (t) positive,
there will be unmeasured confounding, because those with a small gain in BMI
are more likely to have preclinical disease than those with a substantial gain.
It follows that one requires an analytic method that can adjust for unmea-
sured confounding due to the prescence of preclinical disease. I will present a
method that is appropriate under the additional assumption that we are able to
specify an upper bound on the length of time a subject may have a subclinical
illness severe enough to affect his weight, before that illness becomes clinically
manifest.
2.2.2 Measured Confounders that are also Intermediate Variables
I next turn to the issue of confounding by measured factors, i.e., by components
of the covariate vector L (t) . For pedagogic purposes, in this subsection, it will
be simpler to imagine that the unmeasured confounding due to reverse causa-
tion discussed above is not present. Now it is fairly well accepted that obesity
causes increased blood pressure (BP), increased low density lipoproteins (LDL),
diabetes (Db), and decreased exercise and these four factors may in turn cause
increased mortality. Thus these four variables are intermediate variables on the
causal pathway from BMI to mortality. In order to prevent underestimation of
the overall effect of BMI on mortality due to adjusting for intermediate vari-
ables, many analyses of the effect of BMI on mortality have failed to adjust for
BP, LDL , Db, or exercise in the analysis. However such a decison can only be
justified if these potential intermediate variables do not also confound the BMI-
mortality relationship.
A sufficient conditon for these intermediate variables to also be confounders
is that, among subjects with identical BMI history
(
BMI (0) , A∗ (t− 1)
)
until
t, the subset whose monthly change A∗ (t) in BMI is negative are not comparable
with regard to past BP, LDL, Db, and exercise history to the subset with positive
A∗ (t) . Such non-comparability implies that, if data on time-varying BP, LDL,
Db, and exercise history are not used in the analysis, their will exist a non-causal
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association between an increase of A∗ (t) in BMI during month t and subsequent
adverse mortality, even under the null hypothesis of no overall effect of BMI
on mortality. Such non-comparability can occur whenever some or all of these
intermediate variables are either a cause of a change in BMI or are correlated
with an unmeasured cause of a change in BMI
For example, it is likely that lack of exercise causes weight gain. In that
case, if regular exercise causes decreased mortality, then, in an analysis that
fails to adjust for exercise history prior to t, the association between an increase
of A∗ (t) in BMI during month t and subsequent adverse mortality will be an
overestimate of the true causal effect of A∗ (t) on mortality, due to uncontrolled
confounding by exercise.
Similarly, suppose that chronic emotional stress and low grade depression not
only cause weight gain by inducing overeating as a soothing, self-medicating be-
havior, but also directly cause elevated BP, elevated LDL, and Db independently
via various stress-induced metabolic, immune, and sympathetic nervous system
effects. If, as is true in most observational data bases, data on chronic emotional
stress and low grade depression are not recorded (i.e., measured), then, even un-
der the null hypothesis of no overall effect of BMI on mortality, the association
between an increase A∗ (t) in BMI and subsequent adverse mortality will tend
to be positive, whether or not one adjusts for elevated BP, elevated LDL, and
Db in the analysis, due to uncontrolled confounding by chronic emotional stress
and low grade depression. However, these variables should be adjusted for in the
analysis, because the magnitude of positive overestimation will often be much
less if they are adjusted for, because of their correlation with the unmeasured
causal confounder - chronic emotional stress and depression.
In contrast with the last paragraph, suppose there is no confounding by
chronic emotional stress and low grade depression; rather, in the observational
data base, most indivivduals who developed an elevated BP, elevated LDL, or
Db became concerned about their health and instituted a diet that resulted
in their gaining less weight than those without these conditions. Then the
association found between an increase A∗ (t) in BMI and subsequent adverse
mortality in an analysis that fails to adjust for these variables at t would tend
to underestimate the true causal effect of BMI on mortality due to negative
confounding. I conclude that elevated BP, elevated LDL, and Db could confound
the association between increase in BMI and subsequent adverse mortality in
either a negative or positive direction, depending on which of the mechanisms
described in this paragraph and the last predominates.
In summary, time-dependent covariates such as exercise (i.e., physical ac-
tivity), BP, LDL, or Db that are recorded in L (t) may be both intermediate
variables on the causal pathway from BMI to death and confounders of the
BMI-death relationship. It follows that one requires an analytic method that
can appropriately adjust for the effects of measured time-varying covariates that
are simultaneously intermediate variables and time-dependent confounders.
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2.2.3 Intractable Unmeasured Confounding in Subgroups
There may be subgroups defined by measured variables in whom confounding
by unmeasured factors is intractable. For example, among persons with diag-
nosed chronic renal, liver, pulmonary or cardiac disease, rapid weight gain can
indicate increasing edema (water retention) due to unmeasured disease progres-
sion rather than increasing fat stores; as a consequence, among chronic disease
patients with identical pasts, comparability would not hold because individuals
experiencing rapid weight gain may be at increased risk of death due to unmea-
sured progression of disease compared to those with lesser weight gain. In such
a case unmeasured confounding by disease progression may be intractable.
Using other arguments, various investigators have argued that in both the
subgroup of subjects over age 70 and the subgroup with BMI less than 21,
subjects gaining weight at different rates are not comparable owing to unmea-
sured confounding factors, even when data has been collected on many potential
confounders. .
Therefore one needs an analytic method that can remain valid even when
there exists intractable confounding among subjects with a diagnosed chronic
disease, an age of greater than 70, or a BMI below 21. In the next section, I
describe an analytic method that satisfies the requirements of this and the two
previous subsections.
2.3 A Simplified Description of G-estimation of Structural
Nested Models (SNMs):
In this subsection I give a nontechnical, conceptual description of how, even
in the prescence of the measured and unmeasured confounding described in
Section 2.2, g-estimation of structural nested models can be used to estimate
the expected utility had, contrary to fact, all non-smoking 18 year old American
men in 1950 been put on a stringent mandatory diet that guaranteed that no
one would ever weigh more than their weight at age 18. In order to avoid
technical digressions and thereby keep the description centered on important
conceptual issues, this nontechnical description is neither complete nor fully
accurate. Section 3 onwards provides a complete and accurate description. This
completeness and accuracy unfortunately place greater technical demands on the
reader.
A locally rank preserving SNM for Y is a rule that takes as input a subject’s
observed utility Y, their observed BMI and covariate history through the end
of the study, and an unknown parameter β∗ and outputs the utility Y0 that
would have been observed if, possibly contrary to fact, the subject had followed
the dietary intervention of the first paragraph of the Introduction. If the rule is
correct and we knew the value of β∗, then we could calculate Y0 for each study
subject. The average of these Y0 in the cohort of all non-smoking 18 year old
American men in 1950 is our quantity of interest: the expected (i.e. average)
utility had one implemented a dietary intervention that guaranteed that no one
would ever weigh more than they did at age 18. However we do not know the
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value of β∗. Thus the challenge is to estimate β∗ from the data. When, as in
section 2.2.2, all confounding is due to measured variables, Robins (12) proposed
a method of estimation called g-estimation that is described next.
If the only confounding is due to measured factors, then among subjects with
the same BMI and covariate history prior to time t with nonnegative A (t), the
increase A(t) in BMI between t and t+1 will be conditionally uncorrelated with
Y0. Thus to estimate β
∗, we simply try many different guesses β. If a particular
guess β were the true β∗, then the output of the rule would be uncorrelated
with A(t). Thus I choose as our estimate β̂ of β∗, the guess β which results in
an output that has smallest conditional correlation with A(t) when we combine
the information across all months t from 0 to end of follow-up at K + 1.
When as in Section 2.2.3, there are certain identifiable subgroups in whom
confounding is intractable, bias can result because the output of the rule will be
conditionally correlated with A (t) even when β = β∗. To eliminate this bias,
it suffices to search for lack of correlation with A (t) only among the subset of
subjects who are not members of these intractable confounded subgroups at
time t.That is, we simply restrict our g-estimation procedure at a given time t
to subjects who are not currently members of these subgroups.
When there is unmeasured confounding by subclinical disease such as in
Section 2.2.1, I must modify our g-estimation procedure. Suppose one can
specify an upper bound, say 6 years, on the length of time a subject may have a
subclinical illness severe enough to affect weight gain, before that illness becomes
clinically manifest. Then one can still validly estimate β∗ if one restricts the
g-estimation procedure at a given time t to those subjects who would have
remained alive and free of a diagnosed chronic (i.e., of clinical) disease for the
six years following t had, possibly contrary to fact, they followed a diet that
prevented any further weight gain over those 6 years; by our assumption of a
6-year upper bound, such subjects did not have their weight gain affected by
an undiagnosed chronic disease. [It does not suffice to restrict to subjects who
actually remained alive and free of clinical disease for the six years following
t, because if BMI change A (t) at t causally effects the onset of clinical disease
and/or survival in the following six years, the variable ’survival without clinical
disease for six years after t’ is a response affected by the exposure A (t) and
thus cannot be adjusted for without introducing selection bias as explained in
Hernan et al. (13). Thus to validly estimate β∗ using g-estimation, one must
be able to determine those ”subjects who would have remained alive and free of
clinical disease for the six years following t had, possibly contrary to fact, they
followed a diet that prevented any further weight gain over those 6 years.”
One can do so by specfying a second SNM, called a locally rank preserving
structural nested failure time model (SNFTM), for the effect of change in BMI
on the time X to the diagnosis of chronic disease or death (whichever comes
first). A locally rank preserving SNFTM is a rule that takes as input a sub-
ject’s observed time X to (the earlier of) death or a diagnosed chronic disease,
their observed BMI and covariate history through the end of the study, and
an unknown parameter ψ∗, and a time t and outputs the time Xt that would
have been observed if, possibly contrary to fact, the subject had followed a di-
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etary intervention in which no further weight was gained after time t. If ψ∗ were
known or well-estimated, we could compute Xt for each subject, determine
which subjects’ Xt failed to exceed t by more than 6 years, and exclude such
subjects from the g-estimation procedure used to estimate β∗.
Thus it only remain to estimate the parameter ψ∗ of our locally rank preserv-
ing SNFTM in the prescence of unmeasured confounding by subclinical disease.
Now among subjects with the same BMI and covariate history prior to time t
with nonnegative A (t) who are not members of an identifiable subgroup with
intractable confounding, the change A(t) in BMI between t and t + 1 will be
uncorrelated with Xt if we restrict to subjects with Xt exceeding t by more
than 6 years. Thus to estimate ψ∗, I simply try many different guesses ψ. If a
particular guess ψ were the true ψ∗, the output of the SNFTM rule would be
uncorrelated with A(t) when I restrict the g-estimation procedure to subjects
whose output exceeds t by more than 6 years. Thus I choose as the estimate
ψ̂ of ψ∗, the guess ψ which results in an output that, under this restricted g-
estimation procedure, has the smallest conditional correlation with A(t) when I
combine the information across all times t from 0 to end of follow-up at K + 1.
Before proceeding to the more technical part of the paper, I provide a brief
non-technical discussion of several important but subtle points about SNMs.
First, locally rank preserving SNMs assume that the effect of a given increase
in BMI on the utility Y and on X is the same for any two subjects with the
same past measured covariate history. This assumption is biologically implau-
sible since unmeasured genetic and enviromental factors will clearly modify the
magnitude of the effect of weight gain on the responses Y and X . Fortunately,
we prove in Section 3 that our g-estimator of the mean of Y0 remains valid even
if we allow the magnitude of the effect of weight gain on Y and X to be modified
in an arbitrary manner by unmeasured genetic and enviornmental factors.
The description of g-estimation of the parameters ψ∗ of our SNFTM model
for X assumed that the time X to death or diagnosed chronic disease was
available for every study subject. However, by end of follow-up, a number of
study subjects will remain alive and free of chronic disease. Such subjects are
said to be censored. In Section 4, I show how our g-estimation procedures can
be modified to approprately account for these censored observations.
The estimate of the mean of Y0 will be biased if either the SNMM for Y or
the SNFTM for X are misspecified. I discuss below how to construct tests for
misspecification. However, I also show that the power of such tests to detect
model misspecification can be quite limited in the prescence of reverse causation
by subclinical disease and intractable confounding in identifiable subgroups. In
Section 3.3, I offer some suggestions on how the impact of this limited power
on the quality of one’s inferences can be lessened if one is willing to change the
parameter that is being estimated.
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3 Estimation of the effect of the ”maintain base-
line weight intervention”
In this section I describe how we can use G-estimation of structural nested
nodels (SNMs) to estimate the the expected utility had one put all non-smoking
18 year old American men on a stringent mandatory diet that guaranteed that
no one would ever weigh more than their baseline weight established at age 18.
For pedagogic reasons I first consider the simpler setting in which there is no
unmeasured confounding by preclinical disease.
3.1 Case 1: No unmeasured confounding by preclinical
disease.
3.1.1 A Locally Rank Preserving SNM.
An SNM is a model for counterfactual variables Ym that denote a subject’s
utility measured at end of follow-up under the following counterfactual dietary
intervention:
Time m Dietary Intervention: The subject follows his observed diet up
to monthm following his 18th birthday and, from monthm onwards, the subject
is weighed every day: (i) whenever his weight is greater than or equal to his maxi-
mummonthly BMI up tom [i.e., BMImax (m) ≡ max {BMI (0) , ...., BMI (m)}],
the subject’s caloric intake is restricted until the subject’s BMI falls to below
BMImax (m); (ii) whenever his weight is less than BMImax (m) , the subject is
allowed to eat as he pleases without any intervention.
A subject’s responses had, possibly contrary to fact, he been made to follow
a time m dietary intervention are referred to as counterfactual responses. We
assume that Ym is well-define in the sense that its value is insensitive to the
unspecified details of exactly how the subject’s calories are to be restricted in
(i). We also assume a subject’s counterfactual responses are observed only for
those m for which a subject’s actual BMI history was consistent with his having
followed the time m dietary intervention. For other values of m, the time m-
specific counterfactuals remain unobserved.
The time 0 dietary intervention is the dietary intervention in the first para-
graph of the Introduction. The counterfactual Y0 is the utility corresponding
to this regime. Thus the expected value E [Y0] of Y0 is our parameter of interest:
the expected utility had we placed in 1950 all non-smoking 18 year old American
men on a diet that guaranteed that no one would ever weigh more than they
did at age 18.
Note that YK+1=Y : if one were to follow his actual observed diet up to the
time K + 1 at which the study ends, then no dietary intervention would have
occurred. Hence the counterfactual YK+1 must be the observed (i.e., actual) Y.
By definition, a subject’s observed data through k (but before k + 1) is
inconsistent or incompatible with following the ”time m dietary intervention” if
and only if BMI (k + 1) > BMImax (m) for some k > m.
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Let us define A (t) to be the difference between a subject’s observed BMI,
BMI (t+ 1), just prior to month t + 1 and his maximum value BMImax (t)
of BMI prior to month t, whenever that difference is nonnegative. When the
difference is negative, we simply set A (t) to be zero. Formally then
A (t) = BMI (t+ 1)−BMImax (t) if BMI (t+ 1) ≥ BMImax (t) (2)
A (t) = 0 if BMI (t+ 1) < BMImax (t) . (3)
A (t) is nonnegative. It follows that it is only when the individual’s observed
data is incompatible with the ”time m dietary intervention” through time m is
A (m) 6= 0. If an individual’s observed data is consistent with his having followed
the ”time m dietary intervention”, it is consistent with his having followed the
”time t dietary intervention” for t > m.
Note that Ym+1 − Ym = 0 whenever A (m) = 0. If A (m) 6= 0, Ym+1 −
Ym is the difference between (i) a subject’s utility when he has his observed
BMI (m+ 1) history and thereafter, possibly contrary to fact, the subject
follows the dietary intervention that guarantees his BMI (k) for k > m + 1
never again exceeds BMI (m+ 1) and (ii) his utility when he has his observed
BMI (m) history and thereafter, possibly contrary to fact, the subject follows
the dietary intervention that guarantees his BMI at m+ 1 equals his observed
BMImax (m) [rather than his observed BMI at m+ 1] and that his BMI (k)
for k > m+1 never again exceeds BMImax (m) . As a kind of shorthand for the
previous sentence, whenever A (m) 6= 0, we will refer to Ym+1−Ym as the causal
effect of final blip of exposure of magnitude A (m) on the subject’s utility.
An additive locally rank preserving SNM is a deterministic model for the
magnitude of the effect of a treatment A(m) on Ym+1− Ym. Mathematically an
additive locally rank preserving SNM assumes that for each time m = 0, ...,K,
Ym+1 − Ym = γm
[
A(m), A (m− 1) , L (m) , β∗
]
(4)
where (i) β∗ is the unknown true parameter vector, and (ii) γm
[
A(m), A (m− 1) , L (m) , β
]
is a known function [such as
{
β0 + β1m+ β
T
2 L (m)
}
A (m)] satisfying the re-
strictions γm
[
A(m), A (m− 1) , L (m) , β
]
= 0 if A (m) = 0 or β = 0. Here θ2 is
a column vector of length equal to that of the vector L (m). Furthermore, T as
a superscript denotes the transpose of a matrix or vector. The first restriction
must logically hold because, by definition, if A (m) = 0, Ym+1 = Ym. We now
show that the second restriction guarantees that β∗ = 0 encodes the sharp null
hypothesis that ”following a diet that prevents one’s BMI from ever exceeding
the baseline BMI” has no effect on any subject’s utility.
Recalling that YK+1 = Y, the model (4) is seen to be equivalent to the model
Ym = Y −
K∑
m
γm
[
A(m), A (m− 1) , L (m) , β∗
]
(5)
for m=0,1,...,K. To help understand equation (5) consider first the special case
m = K. Then equation (5) says that to calculate YK from Y, we remove
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the causal effect γK
[
A(K), A (K − 1) , L (K) , β∗
]
of exposure A(K) at the last
time K. Next consider the special case m = 0. Then equation (5) says that to
calculate Y0, one successively removes the effect of exposure at times K,K −
1, ..., 0. It follows from the restriction γm
[
A(m), A (m− 1) , L (m) , 0
]
= 0 that
β∗ = 0 implies γm
[
A(m), A (m− 1) , L (m) , β∗
]
= 0 for each m. Thus β∗ = 0
encodes the sharp null hypothesis that Y0 = Ym = Y for all subjects and allm.In
other words, one’s utility at the end of the study will be the same regardless of
whether or not one follows any ”time m dietary intervention”.
Since, by Eq. (5), a locally rank preserving SNM directly maps an individuals
observed utility Y to the utility an individual would have under the ”time m
dietary intervention”, it is a model for individual causal effects.
Possible choices of γm
[
a(m), a (m− 1) , l (m) , β
]
include (i) βa (m),
(ii) (β0 + β1m) a (m), (iii)
{
β0 + β1m+ β
T
2 l (m)
}
a (m). In model (i), the
effect of a change of A(m) in BMI is the same for all m. Under model (ii), the
effect varies linearly with time m . Under model (iii), the causal effect of A (m)
is modified by the most recent covariate history.
In the following we assume the observed data O on each subject is O =(
Y, L,A
)
≡
(
Y, L (K + 1) , A (K)
)
. That is O consists of a subject’s utility Y
and his covariate and treatment histories through the end of the study. The
inclusion of A (K) is actually redundant, since the A−history A(K) is deter-
mined by BMI (K + 1) , and BMI (K + 1) is a component of L(K + 1). Thus
we could write the observed data as simply
(
Y, L (K + 1)
)
. However because
we wish to use results on g-estimation of SNMs that were derived in previous
papers in which A(K) was not determined by L(K + 1), we will continue to
write O =
(
Y, L,A
)
and accept some redundancy in the notation. Let
Ym (β) = Y −
K∑
j=m
γm
[
A(j), A (j − 1) , L (j) , β
]
(6)
so, under our model, Ym = Ym (β
∗) . Note that, for each β, Ym (β) can be com-
puted from the observed data
(
Y, L,A
)
. Suppose we had a consistent estimate
β̂ of β∗. Then Y0
(
β̂
)
would be a consistent estimate of Y0 = Y0 (β
∗) . Thus the
average
∑n
i=1 Y0i
(
β̂
)
/n over the n study subjects would be a consistent esti-
mate of the parameter of interest E [Y0] . Further
∑n
i=1 Y0i
(
β̂
)
/n−
∑n
i=1 Yi/n
would be a consistent estimate of the difference E [Y0] − E [Y ] between the
expected utility E [Y0] under a dietary intervention guaranteeing BMI never ex-
cedes the baseline BMI and the expected utility E [Y ] in the abscence of any
dietary intervention. Below we show how one can obtain a consistent estimate
β̂ by g-estimation if a certain comparability assumption holds.
The Innovative Aspect of our SNM: The most important and innova-
tive aspect of our model is that it models the causal effect on the utility of an
increase in BMI of A (m) over a subject’s maximum past BMI, BMImax (m) . It
does not model and thus is agnostic about the causal effect a) of any decrease
in BMI or b) of any increase in BMI between m and m+ 1 that fails to result
13
in one’s BMI exceeding BMImax (m) . Our model (4) is thus more robust than
alternative models that would also model a) or b). However, the small number
of assumptions made by our model are sufficient for our purposes; if we can con-
sistently estimate the parameter β∗, we can consistently estimate our parameter
of interest E [Y0] .
Thus it only remains to estimate β∗. In this section will do so under the
following assumption, which will be weakened in later sections. Define the
indicator variable Ξ (m) taking values in the two-element set {0, 1} by
Ξ (m) = 1⇔ BMI (m+ 1) ≥ BMImax (m) (7)
That is Ξ (m) takes the value 1 if a subject’s BMI just before m+ 1 is at least
as great as his maximum BMI up to time m. Otherwise Ξ (m) takes the value
0.
Comparability Assumption (CO): Among subjects with the same A(m−
1) history and covariate history L(m) (which includes BMI history BMI (m))
and with Ξ (m) = 1, A (m) is statistically independent of the counterfactual
Ym. Formally, conditional on
(
A(m− 1), L(m),Ξ (m) = 1
)
, A (m) is indepen-
dent of Ym. [Since past A−history A(m−1) is determined by BMI (m), A(m−1)
in the conditioning event
(
A(m− 1), L(m)
)
is redundant; nonetheless we shall
retain the A(m− 1).]
A comparability assumption such as CO is often referred to as an asssump-
tion of no confounding by unmeasured factors or as an assumption of sequential
randomization.
Remark: To understand why we conditioned on Ξ (m) = 1 in the CO
assumption, imagine we had instead assumed that A (m) is independent of Ym
conditional on
(
A(m− 1), L(m)
)
. That would have implied that among the sub-
set of subjects with a given
(
A(m− 1), L(m)
)
, the subgroup with A (m) 6= 0
would have the same distribution of the utility Ym under the time m− dietary
intervention as the subgroup with A (m) = 0. But, under the time m− inter-
vention, all subjects in the A (m) 6= 0 subgroup would have BMI(m+ 1) equal
to their common BMImax (m) ∈ L(m), while many subjects with A (m) = 0
(specifically, those with Ξ (m) = 0) would have BMI(m+ 1) < BMImax (m) .
Thus, the A (m) = 0 subgroup will have lower BMI at m+1 than the A (m) 6= 0
subgroup under the time m− intervention. Suppose the null hypothesis of no bi-
ological BMI effect is false. Then, for an individual with A (m) = 0, their utility
Ym should depend on their BMI atm+1. As such, it extremely unlikely that the
A (m) = 0 and A (m) 6= 0 subgroups would be comparable. In contrast, if, as in
assumption CO, we restrict the A (m) = 0 subgroup to a subset of the subjects
with Ξ (m) = 1, then given L(m), this restricted A (m) = 0 subgroup, like the
A (m) 6= 0 subgroup, will have BMI(m+ 1) equal to the common BMImax (m)
under the intervention, so the assumption of noncomparability is plausible.
It is interesting to note that if we had used the coding convention that vector
L (k) includes Ξ (k) as a component, we could then have stated our comparabil-
ity assumption as A (m) is independent of Ym conditional on
(
A(m− 1), L(m)
)
because, under this coding, pr
(
A (k) = 0|A¯ (k − 1) = 0¯ (k − 1) , L¯ (k)
)
is one
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whenever Ξ (k) takes the value zero. However, we will not use this coding
convention.
Under the CO assumption, we can obtain a consistent estimator of β∗ by
g-estimation as follows. We specify a linear regression model
E
[
A (m) |L(m), A(m− 1),Ξ (m) = 1
]
= αTW (m) for m = 0, ...,K. Here
W (m) = wm
[
L(m), A(m− 1)
]
is a vector of covariates calculated from a sub-
ject’s past data, αT is a row vector of unknown parameters, and each person-
month is treated as an independent observation, so each person contributes up
to K + 1 observations. However, person months for which Ξ (m) 6= 1 are ex-
cluded from the regression. Examples of W (m) = wm
[
L(m), A(m− 1)
]
would
be the transpose of the row vector (m,LT (m), LT (m − 1)). Let α̂ be the OLS
estimator of α computed using a standard statistical package.
For the moment assume β is one dimensional. Let βlow and βup be much
smaller and larger, respectively, than any substantively plausible value of β∗.
Then, separately, for each β on a grid from βlow to βup, say βlow, βlow +
0.1, βlow + 0.2, ..., βup, perform the score test of the hypothesis θ = 0 in the
extended linear model
E
[
A (m) |L(m), A(m− 1), Ym (β) ,Ξ (m) = 1
]
= αTW (m) + θYm (β) (8)
that adds the covariate Ym (β) at each time m to the above (pooled over persons
and time) linear model. A 95% confidence interval for β∗ is the set of β for which
an α = 0.05 two-sided score test of the hypothesis θ = 0 does not reject. The
g-estimate β̂ of β∗ is the value of β for which the score test takes the value zero
(i.e., the p-value is one).
The validity of g-estimation is proved as follows. By our comparability
assumption Ym (β
∗) and A(m) are conditionally independent given(
L(m), A(m− 1),Ξ (m) = 1
)
. That is, Ym (β
∗) is not a predictor of A(m)
given
(
L(m), A(m− 1),Ξ (m) = 1
)
, which implies that the coefficient θ of Ym (β) must
be zero in the extended model when β = β∗, provided the model
E
[
A (m) |L(m), A(m− 1),Ξ (m) = 1
]
= αTW (m) is correctly specified.
Now, we do not know the true value of β. Therefore, any value β for which
the data are consistent with the parameter θ of the term θYm (β) being zero
might be the true β∗, and thus belongs in our confidence interval. If consistency
with the data is defined at the 0.05 level, then our confidence interval will have
coverage of 95%. Furthermore, the g-estimate β̂ of β∗ is that β for which adding
the term θYm (β) does not help to predict A (m) whatsoever, which is the β for
which the score test of θ = 0 is precisely zero. The g-estimate β̂ is also the value
of β for which the OLS estimator of θ is precisely zero.
It may appear peculiar that a function Ym (β) of the response Y measured
at end of follow-up is being used to predict A (m) at earlier times. However,
this peculiarity evaporates when one recalls that, for each β on our grid, we
are testing the null hypothesis that β = β∗, and, under this null, Ym (β) is the
counterfactual Ym, which we can view as already existing at time m (although
we cannot observe its value until time K+1 and then only if A(t) in the observed
data is zero from m onwards).
15
Suppose next that the parameter β is a vector. To be concrete suppose we
consider the model with
γm
[
a (m) , a(m− 1), l (m) , β
]
= a (m)
{
β0 + β1m+ β
T
3 l (m)
}
so β is of di-
mension dim(l (m)) + 2 where dim(l (m)) is the dimension of l (m) which, for
concreteness, we take to be 3. Hence β is 5 dimensional. Then we would
use a 5 dimensional grid, one dimension for each component of β. So if we
had 20 grid points for each component, we would have 205 different values of
β on our 5 dimensional grid. Now to estimate 5 parameters one requires 5
additional covariates. Specifically, let Qm (β) = qm
[
L¯(m), A¯(m− 1), Ym (β)
]
be a 5 dimensional vector of functions of
(
L¯(m), A¯(m− 1), Ym (β)
)
, such as
Qm (β) =
[
1,m, LT (m)
]
(Ym (β))
2
. We use the extended model
E
[
A (m) |L(m), A(m− 1), Ym (β) ,Ξ (m) = 1
]
= αTW (m) + θTQm (β) .
Our g-estimate β̂ is the β for which the 5 degree of freedom score test that
all 5 components of θ equal zero is precisely zero. The particular choice of the
functions qm does not affect the consistency of the point estimate, but it affects
the width of the confidence interval.
When γm
[
a (m) , a(m− 1), l (m) , β
]
= a (m)βTRm is linear in β with Rm =
rm
(
L¯(m), A(m− 1)
)
being a vector of known functions and we chooseQm (β) =
Q∗mYm (β) linear in Ym (β), then, given the OLS estimator α̂
T of αT in the
model E
[
A (m) |L(m), A(m− 1)
]
= αTW (m)), there is an explicit closed form
expression for β̂ given by
β̂ =

i=n,m=K∑
i=1,m=0
Ξi (m)Ai (m)Gim (α̂)Q
∗
imS
T
im

−1
i=n,m=K∑
i=1,m=0
Ξi (m)YiGim (α̂)Q
∗
im

(9)
with Gim (α̂) =
[
Ai (m)− α̂
TWi(m)
]
, Sim =
∑i=n,j=K
i=1,j=m Rij .
Identification : Suppose that two different values of β, say β̂ and
̂̂
β, both
make the 5 degree of freedom score test precisely zero and yet the two CI for
β∗ centered at β̂ and
̂̂
β do not overlap. How should we choose between the
estimates? [In such a case, the matrix whose inverse is required in (9) will not
be invertible and so (9) will fail.] Since we can use any 5 vector Qm (β) =
qm
[
L¯(m), A¯(m− 1), Ym (β)
]
in our procedure, one simple approach is to try
other choices of Qm (β) until we find a Qm (β) for which our CI for β
∗ includes
only one of the β̂ and
̂̂
β , declare the one included to be our point estimate
of β∗ and ignore the excluded one. Will this approach always succeeed? In
general this approach should succeed in rather quickly excluding all but one of
the values of β that originally made the score test zero, provided that the model
γm
[
a (m) , a(m− 1), l (m) , β
]
is correct, except when β∗ is not identified. By
definition β∗ is not identified if there is a β∗∗ different from the true parameter
β∗ such that, with an infinite sample size, β∗∗, like β∗, makes the 5 degree
of freedom score test precisely zero for all choices of Qm (β) . In our model, it
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follows from Robins (3, 4) that under the positivity assumption that
Pr
[
A (m) = 0|A (m− 1) , L (m) ,Ξ (m) = 1
]
6= 0 (10)
for all subjects and m = 0, ...,K, β∗ is identified. In our context the positivity
assumption is a very weak assumption, that is almost certainly true. Hence, for
the remainder of the paper, we will silently assume that it holds.
Remark: We considered a linear regression model for
E
[
A (m) |L(m), A(m− 1), Ym (β) ,Ξ (m) = 1
]
in the above for expositonal
simplicity. In practice since A (m) ≥ 0, we might use a log linear model that
specifies
E
[
A (m) |L(m), A(m− 1), Ym (β) ,Ξ (m) = 1
]
= exp
{
αTW (m) + θTQm (β)
}
and
fit by non-linear least squares. In that case, in the last display, Gim (α̂) =[
Ai (m)− exp
{
α̂TWi(m)
}]
. Alternatively we could replace the repsonse vari-
able A (m) in the linear regression by ln (Am + 0.1) where the 0.1 is added to
insure the logarithm remains finite even when Am = 0. In that case, Gim (α̂) =[
ln {Ai (m) + 0.1} − α̂
TWi(m)
]
3.1.2 An additive structural nested mean model (SNMM)
An additive locally rank preserving SNM (4) implies that if two subjects have the
same observed data O =
(
Y, L,A
)
they will have the same value of Y0 under the
”time 0 dietary intervention” of the introduction. That is the model implies that
for these subjects, the effect of the ”time 0 dietary intervention” will be identical.
This assumption is clearly biologically implausible in view of between-subject
heterogeneity in unmeasured genetic and environmental factors. To overcome
this limitation, we consider an additive structural nested mean model (SNMM)
E
[
Ym+1 − Ym|A (m) , L (m)
]
= γm
[
A(m), A (m− 1) , L (m) , β∗
]
(11)
that models the conditional mean of Ym+1−Ym given
(
A (m) , L (m)
)
rather than
the individual differences Ym+1−Ym, and thus does not impose local rank preser-
vation. In particular Ym no longer is equal to Ym (β
∗) . However, Robins (4, 5)
proved the additive SNMM implies (and, in fact is equivalent to ) the assump-
tion that Ym and Ym (β
∗) have the same mean given A (m) , L (m) ,Ξ (m) = 1.
That is
E
[
Ym|A (m) , L (m)
]
= E
[
Ym (β
∗) |A (m) , L (m)
]
(12)
for each m. Further he proved that, under the CO assumption, g-estimation of
β∗ retains all the properties described above, even in the absence of local rank
preservation, except now the function Qm (β) must be chosen linear in Y (β) ,
i.e., Qm (β) = Q
∗
mYm (β) as above.
As a consequence, the definition of non-indentifiability must be modifed
as follows: the parameter β∗ of an SNMM β∗ is not identified if there is a β∗∗
different from the true parameter β∗ such that, with an infinite sample size, β∗∗,
like β∗, makes the 5 degree of freedom score test precisely zero for all choices of
Qm (β) that are linear in Ym (β) . A fuller discussion of rank preserving versus
non-rankpreservng models occurs in Section 3.2.4.
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Alternative Approaches: Under the CO assumption, it is shown in ref
[12] that the E [Ym] are nonparametrically identified for m = 0, ...,K from data
O =
(
Y, L,A
)
by the IPTW formula
E [Y I {A (m) = 0 (m)}W (m)] , (13)
where A (m) = (A (m) , ..., A (K)) and the IPTW weight
W (m) = 1/
K∏
k=m
{
pr
(
A (k) = 0|A (k − 1) , L (k)
)}Ξ(k)
is the inverse of the conditional probability that a subject had his observed
treatment A (m) = 0 (m). That is, E [Ym] is the weighted mean of the observed
utility Y among subjects who observed data was consistent with following the
time m dietary intervention with weights given by the inverse of the conditional
probability of having data consistent with following the intervention. Thus
one could, in principle, consider estimating E [Y0] nonparametrically by the
weighted average of Y among subjects whose weight never exceeded their base-
line weight at age 18 with weights proportional to an estimate Ŵ (0) of W (0) .
That is, by
 ∑
{i;Ai(0)=0(0)}
Ŵi (0)Yi
 /
 ∑
{i;Ai(0)=0(0)}
Ŵi (0)
 . The problem with
this approach is that only the utility Y of the rare person whose weight never
exceeds his age 18 weight contributes to the analysis. In contrast by specifying
a SNMM, data on the utility Y of every subject contributes to the estimate of
E [Y0] . The price paid for the greater efficiency of a SNMM is the possibility of
bias if the SNMM (11) is misspecified.
However, under the CO, E
[
Ym|A (m) , L (m)
]
= E
[
Ym|A (m− 1) , L (m)
]
and is nonparametrically identified by the formula
E
[
Y I {A (m) = 0 (m)} /W (m) |L (m) , A (m− 1)
]
. ThusE
[
Ym+1 − Ym|A (m) , L (m)
]
is nonparametrically identified for m=0,...,K. Hence, given a sufficiently large
sample size, one could in principle construct misspecification tests of the model
(11) that have power against all alternatives when the model is incorrect. In
practice, the available sample size may greatly limit the power to detect model
misspecification.
IPTW estimation of marginal structural models and the parametric g-formula
are alternative approaches to model-based estimation of E [Y0] that also use data
on every subject’s utility Y . See Appendix 2 for further discussion of the latter
approach.
Remark: The reader familiar with IPTW expects W (m) to be defined as
W (m) = 1/
k
Π
k=m
{
pr
(
A (k) = 0|A¯ (k − 1) = 0 (k − 1) , L¯ (k)
)}
rather than as
1/
K
Π
k=m
{
pr
(
A (k) = 0|A¯ (k − 1) = 0¯ (k − 1) , L¯ (k)
)}Ξ(k)
. In fact, the two expres-
sion would have been equal had we used the coding convention that the vector
L (k) includes Ξ (k) as a component because, under this coding, pr
(
A (k) = 0|A¯ (k − 1) = 0¯ (k − 1) , L¯ (k)
)
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is one whenever Ξ (k) takes the value zero. However, we do not use this con-
vention.
3.2 Case 2: Unmeasured confounding by preclinical dis-
ease.
In this section we no longer assume A(m) is statistically independent of Ym given
A (m− 1) , L(m),Ξ (m) = 1. To describe our new comparability assumption we
need to introduce some further notation. Let X = min (T,D) be the minimum
of the time T to death and the time D to the diagnosis of a chronic disease,
such as cancer, severe emphysema, liver or renal disease, or any other chronic
condition that would be severe enough to affect weight gain. At each time m,
the indicator I (X ≤ m) is a component of L (m) . Further if I (X ≤ m) = 1,
the exact time X is observed and included in L (m) . Thus X is observed if X
is less than K+1. However X is censored (i.e. not observed) on subjects whose
X exceeds K + 1, the end of follow up time. For the present we shall avoid the
additional complications that arise from censoring by assuming that X is less
than K + 1 for all subjects, so that the data O =
(
Y,X,L,A
)
is observed on
each subject. In Section 4, we relax this assumption and allow for censoring.
Let Xm = min (Tm,Dm) be the counterfactual version of X = min (T,D)
had ”the time m dietary intervention” been carried out. Then we make the
following more realistic assumption.
Realistic Comparability (RC) Assumption : A (m) is statistically in-
dependent of (Ym, Xm) given Ξ (m) = 1, L(m), A (m− 1) and U (m) = 0 (m) ,
where U (m) = 1 if a subject has atm or had prior tom, an undiagnosed chronic
disease that was sufficiently advanced to interfere with his normal weight tra-
jectory. Otherwise U (m) = 0.We also define U (m) = 1 for subject’s alive at m
with X < m under the assumption that there was probably a subclinical period
prior to the time X of clinical diagnosis in which weight gain may have been
altered. Note that U (m) = 0 implies U (m) = (U (0) , ..., U (m)) = 0 (m) is also
zero.
Remark: The RC assumption cannot be recast as (Ym, Xm) independent of
A (m) given
(
L(m), A (m− 1) , U (m)
)
even had we used the coding convention
that vector L (k) includes Ξ (k) as a component, because, even under this cod-
ing, pr
(
A (k) = 0|A¯ (k − 1) = 0¯ (k − 1) , L¯ (k) , U (m) , (Ym, Xm)
)
would be nei-
ther zero nor one and could , under the RC assumption, depend on (Ym, Xm)
whenever U (m) 6= 0 and Ξ (k) = 1. For this reason it would perhaps be more
precise to refer to the RC as a selective comparability assumption as it only
implies comparability for a selected subset of the population.
We observe
(
Y,X,L,A
)
but U (m) = (U (0) , ..., U (m)) is, of course, gen-
erally unobserved when X > m. Thus U is an unmeasured confounder. The
most crucial of several assumptions needed to allow consistent estimation of the
parameter of interest E [Y0] in this setting is the following.
Clinical Detection (CD) Assumption: Any subject who has U (m) = 1
[ie a sufficently advanced undiagnosed chronic disease at ( or before) m] and
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thereafter follows ”the time m dietary intervention” will either have died or
been diagnosed with clinical chronic disease by time m+ ζ, where ζ is assumed
known. Formally
U (m) = 1 ⇒ Xm ≤ m+ ζ (14)
or equivalently
Xm > m+ ζ ⇒ U (m) = 0 (m) (15)
Here ⇒ is translated as ’implies’. A typical choice for ζ might be 72 months.
It is useful to choose ζ to be the minimal time for which (15) holds as this
increases both the effciency of g-estimators and the power of goodness of fit
tests to detect misspecification of a structural nested model and decreases the
likelihood that an SNM is nonidentified. However if the chosen ζ is less then
the true minimum time for which (15) holds bias will result. As a consequence
one should routinely include a table that shows how one’s estimate of E [Y0]
changes as ζ is varied.
The RC and CD assumptions require that one record in X the minimum
time of clinical onset among the set of clinical conditions whose preclinical phase
could affect BMI. The exact clinical conditions that belong in this subset is a
substantive question, about which subject matter experts should be consulted.
Remark: We will later consider the effect of replacing the counterfactual
Xm by the observed X in the CD assumption.
3.2.1 Estimation under a Rank Preserving SNM for Ym|Xm with Xm
known
To consistently estimate E [Y0] under RC and CD we must replace our SNMM
model with an additive SNMM model for Ym|Xm that also conditions on and
allows effect modification by the counterfactual Xm. For pedagogic purposes
in this subsection we return to locally rank preserving models. A locally rank
preserving SNM for Ym|Xm states that
Ym+1 − Ym = γm
[
A(m), A (m− 1) , L (m) , Xm, β
∗
]
(16)
where β∗ is an unknown parameter and γm
[
A(m), A (m− 1) , L (m) , Xm, β
]
is
a known function that can now depend on Xm that takes the value zero if either
A(m) = 0 or β = 0. [We emphasize that it is Xm and not Xm that occurs in
the last display.]. This model is equivalent to assuming
Ym = Ym (β
∗) (17)
for each subject with Ym (β) now redefined as
Ym (β) = Y −
K∑
j=m
γm
[
A(j), A (j − 1) , L (j) , Xj , β
]
(18)
Now, of course the counterfactual variable Xm is itself unobserved. How-
ever for pedagogic purposes in this subsection we unrealisticly assume that in
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addition to the observed data
(
Y,X,L,A
)
, data on the counterfactuals Xm are
available.
Remark: We do not actually require a locally rank preserving SNM for
Ym|Xm. A locally rank preserving SNM for Ym|c (Xm) for a certain known
function c (x) could be used instead. This remark is explored further in the
Appendix.
Redefine Qm (β) = qm
[
L¯(m), A¯(m− 1), Xm, Ym (β)
]
to possibly be a func-
tion of Xm. Consider again the g-estimator β̂ that is equal to the β for which
the 5 degree of freedom score test of θ = 0 is precisely zero in the model
E
[
A (m) |L(m), A(m− 1), Xm,Ξ (m) = 1, Ym (β)
]
= αTW (m) + θTQm (β) .
β̂ would be a CAN estimator of β∗ under the CO assumption, but not under
the RC assumption. Under RC, the independence needed to make θ = 0 when
β=β∗ only holds when we also condition on U (m) .
However, consider the estimator β˜ obtained when, for each time m, we only
fit the previous model to subjects for whom Xm > m+ ζ, excluding all subjects
with Xm ≤ m + ζ. This exclusion can be expressed by saying that we now fit
the model
E
[
A (m) |L(m), A(m− 1), Xm,Ξ (m) = 1, Ym (β) , Xm > m+ ζ
]
= αTW (m)+θTQm (β) .
(19)
Then the estimator β˜ is the β for which the 5 degree of freedom score test of
the hypothesis θ = 0 is precisely zero in this latter model. When Xm > m+ ζ,
U (m) = 0 (m) , by assumption CD. Hence we can rewrite the last display as
E
[
A (m) |L(m), A(m− 1), Xm,Ξ (m) = 1, Ym (β) , Xm > m+ ζ, U (m) = 0 (m)
]
= αTW (m) + θTQm (β) (20)
showing that we have succeeded in conditioning on U (m) = 0 (m) , even though
U (m) is unmeasured! It follows that, when the parameter β∗ is identified,
the estimator β˜ is a consistent and asymptotically normal (CAN) estimator
of β∗ under the RC and CD assumptions, since these assumptions imply the
coefficient θ = 0 if β = β∗. However as discussed further below, under the RC
and CD assumptions, the positivity assumption no longer suffices to guarantee
identification.
In summary, all that was required to produce a CAN estimator β˜ of the
parameter β∗ of our locally rank preserving SNM (17) for Ym|Xmunder the RC
and CD assumptions was to restrict the earlier g-estimation procedure at each
time m to those subjects with Xm > m+ ζ.
Thus if γm
[
A (m) , A(m− 1), L (m) , Xm, β
]
= A (m)βTRm is linear in β
with Rm = rm
(
L¯(m), Xm
)
being a vector of known functions that now can
depend on Xm, then, given the OLS estimator α̂
T of αT in the model
E
[
A (m) |L(m), A(m− 1),Ξ (m) = 1
]
= αTW (m) and Qm (β) = Q
∗
mYm (β) lin-
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ear in Ym (β), the CAN estimator β˜ exists in closed form as
β˜ =

i=n,m=K∑
i=1,m=0
I [Xim > m+ ζ] Ξi (m)Ai (m)Gim (α̂)Q
∗
imS
T
im

−1
(21)
×

i=n,m=K∑
i=1,m=0
I [Xim > m+ ζ] Ξi (m)YiGim (α̂)Q
∗
im

with Gim (α̂) =
[
Ai (m)− α̂
TWi(m)
]
, Sim =
∑i=n,j=K
i=1,j=m Rij .
From the above, it follows that if, in addition to the observed data
(
Y,X,L,A
)
,
data on the counterfactuals Xm are available for each m, the sample average∑n
i Y0
(
β˜
)
/n is a CAN estimator of the parameter of interest E [Y0] under the
RC and CD assumptions, provided β∗ is identified and both our locally rank
preserving SNM for Ym|Xm and our model
E
[
A (m) |L(m), A(m− 1),Ξ (m) = 1
]
= αTW (m) (22)
are correct. Of course data on Xm are unavailable. However in the next sub-
section we prove an analogue of this result holds without data on Xm under a
locally rank preserving SNFTM for the Xm which allows us to replace Xm by
an estimate Xm
(
ψ˜
)
, where ψ˜ estimates the parameter ψ∗ of our SNFTM.
Before preceding to the next subsection, several additional points need to be
made.
Can we replace Xm by X : A natural question that arises is the following.
Suppose we replaced Xm by the observed X in the CD assumption, in our
definition of Ym (β) , and wherever else Xm occurs in this subsection, with the
exception of the RC assumption (as the RC assumption with X replacing Xm
would clearly be false if BMI is a cause of T and/or C and thus of X.). Do β˜
and
∑n
i Y0
(
β˜
)
/n remain CAN estimators of β∗ and E [Y0]? This question is
natural in the sense that it is not obvious that the CD assumption and RP SNM
based on Xm are more likely to be true than when based on X. So were the
answer ”yes” it would be simpler and more straightforward to use X in place
of Xm. In particular, since X, unlike Xm, is observed, we would eliminate the
need to replace Xm with the estimator Xm
(
ψ˜
)
, thereby greatly simplifying the
analysis.
Unfortunately β˜ and thus
∑n
i Y0
(
β˜
)
/n do not remain consistent when we
use X in place of Xm. To see why consider the model
E
[
A (m) |L(m),Ξ (m) = 1, A(m− 1), X, Ym (β) , X > m+ ζ
]
= αTW (m)+θTQmYm (β)
(23)
which has replaced Xm in Eq (19) with X. Clearly β˜ will only be consistent
for the parameter β∗ of our locally RP SNM if θ = 0 when β = β∗. That
is β˜ will only be consistent if Ym = Ym (β
∗) is independent of A (m) given
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(
L(m), A(m− 1),Ξ (m) = 1, X,X > m+ ζ
)
. Now by the CD assumption with
X replacing Xm, X > m + ζ implies U (m) = 0 (m) . Thus consistency of β˜
requires Ym (β
∗) independent of A (m) given(
L(m), A(m− 1),Ξ (m) = 1, X,X > m+ ζ, U (m) = 0 (m)
)
. However, we
show in the next paragraph that this independence statement is not implied by
the RC assumption and thus will generally be false, unless A (k) has no causal
effect on X for k ≥ m in which case X = Xm for each subject and we are back
to Eq. (20).
When A (m) has a causal effect onX (whether directly or through A (k) , k >
m) then X is a common effect of two causes A (m) and Xm that are independent
conditional on the event
(
L(m), A(m− 1),Ξ (m) = 1, U (m) = 0 (m) , Ym (β
∗)
)
.
Therefore, conditional on both the previous event and (X,X > m+ ζ) , A (m)
and Xm are dependent and thus so are A (m) and Ym (β
∗) , since Xm and
Ym (β
∗) are highly correlated, as both are functions of Tm.
However, even when A (m) has a causal effect on X, a slight modification of
the above estimation procedure can be used to obtain CAN estimators of β∗ in
the special case in which A (m) has a known minimal latent period χ for its
effect on X of at least ζ months.
Definition of Minimal Latent Period (MLP) for effect on X: A (m)
has a minimal latent period for its effect on X of χ months if, for every subject
and each time k > m, Xk > m + χ ⇔ Xm > m + χ and Xk = Xm if Xm <
m + χ. In particular by taking k = K + 1, the last two statements become
X > m+ χ⇔ Xm > m+ χ and X = Xm if Xm < m+ χ.
When a known minimal latent period χ exceeds ζ, we can obtain CAN es-
timators of β∗ by simply replacingX > m+ζ by m+χ>X > m+ζ in model (23)
since then the event (X,m+ χ > X > m+ ζ) is the event (Xm,m+ χ > Xm > m+ ζ)
and we are back in the setting of Eq. (19), except for the additional restriction,
m+ χ > Xm, which does not introduce bias. Thus the existence of a minimal
latent period of length χ greater than ζ allows us to estimate β∗ and E [Y0]
without the need to specify a SNFTM for the Xm.
We now prove that under the RC and CD assumptions, a MLP of length χ
greater than ζ implies that
X ∐A (m) |L(m),Ξ (m) = 1, A(m− 1),m+ χ > X > m+ ζ.
It follows that taking the RC and CD assumptions as given, we can test the
hypothesis that a MLP of length χ greater than ζ exists by testing whether
the last display is true. In fact a test of the hypothesis that the parameter ψ∗
of a SNFTM serves as a test of the previous display. To prove our previous
claim note that, by the MLP assumption, the event m + χ > X > m + ζ is
the event m + χ > Xm > m + ζ which, by the CD assumption, is the event
m+χ > Xm > m+ζ, U (m) = 0 (m) . Thus the last display is under the MLP and
CD assumption equivalent to the statement ”Xm is independent of A (m) given(
L(m),Ξ (m) = 1, A(m− 1),m+ χ > Xm > m+ ζ, U (m) = 0 (m)
)
” which is
true by the RC assumption.
Most experts believe it to be substantively implausible that an increase in
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BMI has a minimum latent period of more than 72 months, our default choice
for ζ. In contrast, in occupational cohort studies of the effect of a chemical
carcinogen on time to clinical cancer, minimum latent periods of up to 10 years
are commonly assumed.
3.2.2 Estimation of E [Y0] under a Rank Preserving SNFTM:
As mentioned above, an analogue of the above results hold when data on Xm are
unavailable under under a locally rank preserving SNFTM for Xm. The simplest
locally rank preserving SNFTM specifies that
Xm = m+
∫ X
m
exp (ψ∗A (t)) dt if X > m (24)
Xm = X if X ≤ m, (25)
where ψ∗ is an unknown parameter and A (t) is as defined previously when t is
a whole number of months and A (t) = A (⌊t⌋) when t is not a whole number
where ⌊t⌋ is the largest integer less than or equal to t. Thus, by the definition
of an intergral as the area under a curve,
∫ X
m
exp (ψ∗A (t)) dt =
j=⌊X−1⌋∑
j=m
exp (ψ∗A (j)) + {X − ⌊X⌋} exp (ψ∗A (⌊X⌋)) .
A locally rank preserving SNFTM directly maps an individual’s observed failure
time X to the failure time Xm the individual would have under the ”time m
dietary intervention”. Thus it is a model for individual causal effects. If ψ∗ = 0,
exp (ψ∗A (t)) = 1 and thusXm = m+
∫ X
m
dt = m+X−m = X for anym. Hence
ψ∗ = 0 encodes the sharp null hypothesis that X0 = X for all subjects, i.e., the
”time 0 dietary intervention” has no effect on any subject’s X = min (T,D) . It
is useful to note that when ψ∗ 6= 0, the SNFTM (24)-(25) implies that there is
no minimal latent period for the effect of treatment on X.
A general class (although not the most general class ) of locally RP SNFTMs
that includes the above one parameter model assumes
Xm = m+
∫ X
m
exp
{
ω
(
A (t) , L (t) , ψ∗
)}
dt if X > m (26)
Xm = X if X ≤ m (27)
where ω
(
A (t) , L (t) , ψ
)
≡ ω
(
A (t) , A (t−) , L (t) , ψ
)
is a known function
satisfying ω
(
A (t) , A (t−) , L (t) , ψ
)
= 0 if A (t) = 0 or ψ = 0 and A (t−) is the
A-history until just prior to time t. For example, we might have ω
(
A (t) , A (t−) , L (t) , ψ
)
=
A (t)
{
ψ0 + ψ
T
1 L (t)
}
where L (t) = L (⌊t⌋) and L (⌊t⌋) is as defined earlier.
We next turn to estimation of ψ∗. For the moment, suppose the CO assump-
tion modified to have (Ym, Xm) in place of Ym held and that
(
Y,X,L,A
)
was
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observed. Then we could consistently estimate ψ∗ by g-estimation. Specifically
we define
Xm (ψ) = m+
∫ X
m
exp
{
ω
(
A (t) , L (t) , ψ
)}
dt if X > m (28)
Xm (ψ) = X if X ≤ m (29)
so under our model, Xm = Xm (ψ
∗) . Note that, for each ψ, Xm (ψ) can be com-
puted from the observed data. Suppose, for concreteness, ψ∗ is 5 dimensional so
we search over a 5 dimensional grid. We letQ∗∗m (ψ) = q
∗∗
m
[
L¯(m), A (m− 1) , Xm (ψ)
]
be a 5 dimensional vector of functions of
(
L¯(m), A (m− 1) , Xm (ψ)
)
such as
Q∗∗m (ψ) = Xm (ψ)
[
1,m, LT (m)
]
. We use an extended linear model
E
[
A (m) |L(m), A (m− 1) ,Ξ (m) = 1, Xm (ψ)
]
= αTW (m) + θTQ∗∗m (ψ)
Our g-estimate ψ̂ is the ψ for which the 5 degree of freedom score test that
all 5 components of θ equal zero is precisely zero. Since, by the modified CO
assumption, θ = 0 if ψ = ψ∗, the g-estimate ψ̂ is CAN for ψ∗. The particular
choice of the functions Q∗∗m (ψ) does not affect the consistency of the point
estimate, but it determines the width of its confidence interval. Because Xm (ψ)
is a nonlinear function of ψ, there is not a closed form expression for ψ̂. However
the equation solved by ψ̂ is a smooth function of ψ, so standard methods for
solving nonlinear equations such as the Newton-Raphson algorithm can be used
to compute ψ̂.
Next suppose the observed data is still
(
Y,X,L,A
)
, but the modified CO
assumption does not hold. Rather, the CD and RC assumptions hold. Define
the estimator ψ˜ as the ψ for which the 5 degree of freedom score test of the
hypothesis θ = 0 is precisely zero in the model
E
[
A (m) |L(m), A(m− 1),Ξ (m) = 1, Xm (ψ) , Xm (ψ) > m+ ζ
]
= αTW (m)+θTQ∗∗m (ψ) .
Note the set of subjects who do not contribute to the score test of θ = 0 (i.e sub-
jects with Xm (ψ) ≤ m+ ζ) depends on ψ.When Xm = Xm (ψ
∗) > m+ ζ, then
U (m) = 0 (m) , by assumption CD. Hence, at ψ = ψ∗, our procedure conditions
on U (m) = 0 (m) . It follows that, provided ψ∗ is identified, the estimator ψ˜ is
a CAN estimator of ψ∗ under the RC assumption, as that assumption implies
the coefficient θ = 0 if ψ = ψ∗. However, under the CD and RC assumptions,
the positivity assumption does not guarantee identification.
Now let β˜
(
ψ˜
)
be defined like β˜ except that everywhere Xm
(
ψ˜
)
replaces
Xm, so that β˜
(
ψ˜
)
is a function of the data
(
Y,X,L,A
)
only. Next define
Ym (β, ψ) = Y −
K∑
j=m
γm
[
A(j), A (j − 1) , L (j) , Xj (ψ) , β
]
(30)
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Note, by both models (17) and (26-27) being locally rank preserving, Ym (β
∗, ψ∗) =
Ym. Thus, when ψ
∗ and β∗ are identified, the sample average
∑n
i Y0
[(
β˜
(
ψ˜
)
, ψ˜
)]
/n
is a CAN estimator of the parameter of interest E [Y0] under the RC and CD
assumptions, provided both our locally rank preserving SNM (17) for Ym|Xm,
our locally rank preserving SNFTM (26-27) for Xm, and our model (22) are all
correctly specified.
3.2.3 Estimation of E [Y0] under a SNMM and a SNFTM without
Rank Preservation:
As discused earlier, the assumption of local rank preservation is biologically im-
plausible. Thus we will no longer assume that our locally rank preserving models
(17) and (26-27) are true. As a consequence we can no longer assume that there
exists some (β∗, ψ∗) such that the unobserved counterfactuals (Xm, Ym) equal
the observed (Xm (ψ) , Ym (β, ψ)) when (β, ψ) = (β
∗, ψ∗). However, suppose
with (Xm (ψ) , Ym (β, ψ)) still defined by (28-29), and (30), we assume that , for
each m, there exists some (β∗, ψ∗) such that
Assumption (i): when ψ = ψ∗, Xm and Xm (ψ) have the same conditional
distribution given
(
A (m) , L(m), A(m− 1)
)
and
Assumption (ii)
E
[
Ym|A (m) , L(m), A(m− 1), Xm = x
]
= E
[
Ym (β
∗, ψ∗) |A (m) , L(m), A(m− 1), Xm (ψ
∗) = x
]
(31)
In contrast with the assumption of local RP, there is no apriori biological
reason to exclude the possibility that (i) and (ii) both hold.
When assumptions (i) and (ii) hold for each m, we say the SNMM
γm
[
A(m), A (m− 1) , L (m) , x, β
]
(32)
for Ym|Xm and the SNFTM (28) − (29)) for Xm jointly hold with true pa-
rameter (β∗, ψ∗). If the RC and CD assumptions, the model (22) and (i) and
(ii) all hold, then ψ˜, β˜
(
ψ˜
)
, and
∑n
i Y0
[(
β˜
(
ψ˜
)
, ψ˜
)]
/n as defined previously
are CAN for ψ∗, β∗, and the parameter of interest E [Y0] respectively, provided
(β∗, ψ∗) are identified and we choose Qm (β) linear in Ym (β). [ In contrast,
Q∗∗m (ψ) need not be chosen linear in Xm (ψ) .]. In summary, ψ˜, β˜
(
ψ˜
)
, and∑n
i Y0
[(
β˜
(
ψ˜
)
, ψ˜
)]
/n have the same statistical properties under our joint
SNMM model for Ym|Xm and SNFTM for Xm when local rank preservation
does not hold as when it does.
3.2.4 Are Remarkable Results due to Some Sleight of Hand
The result summarized in the last sentence is striking for a number of reasons.
Our comparability assumption, i.e. the RC assumption, only assumes no un-
measured confounding conditional on U (m) . Yet neither the SNMM for Ym|Xm
nor SNFTM for Xm is a model for causal effects conditional on the unmeasured
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U (m). Thus, it is remarkable that these models can be used to estimate causal
contrasts such as E [Y0] − E [Y ] under the RC and CD assumptions. Further-
more, even though Xm > m+ ζ implies U (m) = 0 (m) by the CD assumption,
nonetheless, in the abscence of local rank preservation, Xm (ψ
∗) > m+ ζ does
not imply U (m) = 0 (m) . Hence when local rank preservation does not hold,
even though we condition on Xm (ψ) > m + ζ in computing our g-estimates
ψ˜, β˜
(
ψ˜
)
, we do not thereby restrict the analysis to a subset of subjects all of
whom have the same value of U (m) ; thus one might guess confounding by the
unmeasured U (m) has not been controlled and our estimates of ψ˜, β˜
(
ψ˜
)
, and∑n
i=1 Y0,i
[(
β˜
(
ψ˜
)
, ψ˜
)]
/n must be inconsistent. Remarkably, such is not the
case.
How did we pull off the seemingly remarkable ’magic’ described in the pre-
ceding paragraph? We shall investigate whether we used some subtle ”sleight of
hand”. We use a simple paradigmatic instance of our model that only involves
a single time-independent exposure to guide our investigation. Specifically, we
next provide an explicit proof that contains no ”sleight of hand” of our results
in the case of a time-independent exposure. The general case is treated in
the appendix. The reader who is interested more in the methodology and less
interested in foundational issues may feel free to skip ahead to section 4.
Paradigmatic Instance of a Time-Independent Exposure: We sup-
pose that K + 1 = 1 so time 0 is the only time of exposure. Further we assume
there are no covariates. In this setting the RC assumption becomes (Y0, X0)
independent of A (0) given the unmeasured confounder U (0) = 0. The CD
assumption becomes X0 > ς implies U (0) = 0. Our SNFTM for X0 becomes
Assumption (i): X0 (ψ) = Xexp(ψA (0)) and X0 have the same condi-
tional distribution given A (0) at ψ = ψ∗,
while our SNMM for Ym|Xm becomes
Assumption (ii): E [Y0|A (0) , X0 = x] = E [Y0 (β
∗, ψ∗) |A (0) , X0 (ψ
∗) = x]
where Y0 (β, ψ) = Y − γ0 [A(0), X0 (ψ) , β] .
Neither model makes any reference to U (0) and thus neither is a model
for causal effects conditional on U (0) . Furthermore, although X0 > ζ implies
U (0) = 0 by the CD assumption, nonetheless X0 (ψ
∗) > ζ does not imply
U (0) = 0. Now to prove our results.
Proofs Of Our Results: Proof that ψ˜ is CAN for ψ∗: By assumption (i),
pr [X0 (ψ
∗) > t|A (0) , X0 (ψ
∗) > ζ] = pr [X0 > t|A (0) , X0 > ζ] . But, by the CD
and then the RC assumptions, pr [X0 > t|A (0) , X0 > ζ]=pr [X0 > t|A (0) , X0 > ζ, U (0) = 0] =
pr [X0 > t|X0 > ζ, U (0) = 0] . Hence pr [X0 (ψ
∗) > t|A (0) , X0 (ψ
∗) > ζ] is not
a function of A (0) . We conclude that A (0) and X0 (ψ
∗) are independent given
X0 (ψ
∗) > ζ. Thus E [A (0) |X0 (ψ
∗) , X0 (ψ
∗) > ζ] = α + θX0 (ψ
∗) has coeffi-
cient θ = 0 so, when ψ∗ is identified, the ψ˜ for which the the score test of θ = 0
takes the value 0 is CAN for ψ∗.
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Proof that β˜
(
ψ˜
)
is CAN for β∗ : By Assumption (ii),
E [Y0 (β
∗, ψ∗) |A (0) , X0 (ψ
∗) = x,X0 (ψ
∗) > ζ] = E [Y0|A (0) , X0 = x,X0 > ζ] .
But, by the CD and then the RC assumptions,
E [Y0|A (0) , X0 = x,X0 > ζ] = E [Y0|A (0) , X0 = x,X0 > ζ, U (0) = 0]
= E [Y0| X0 = x,X0 > ζ, U (0) = 0] is not a function of A (0) .
Thus, 0 = E [Y0 (β
∗, ψ∗) {A (0)− E [A (0) |X0 (ψ
∗) , X0 (ψ
∗) > ζ]}] .
Hence 0 = E [Y0 (β
∗, ψ∗) {A (0)− E [A (0) |X0 (ψ
∗) > ζ]}] .As a consequence,
the β˜
(
ψ˜
)
for which the the score test of θ = 0 takes the value 0 in the model
E
[
A (0) |X0
(
ψ˜
)
> ζ, Y0
(
β, ψ˜
)]
= α+ θY0
(
β, ψ˜
)
is CAN for β∗, when β∗
and ψ∗ are identified.
Proof that
∑n
i=1 Y0,i
[(
β˜
(
ψ˜
)
, ψ˜
)]
/n is CAN for E [Y0] : E [Y0] =∫ ∫
E [Y0|A (0) , X0 = x] dFX0 (x|A0) dF (A0)
=
∫ ∫
E [Y0 (β
∗, ψ∗) |A (0) , X0 (ψ
∗) = x] dFX0(ψ∗) (x|A0) dF (A0) = E [Y0 (β
∗, ψ∗)] by
assumptions (i) and (ii). Hence ,
∑n
i=1 Y0,i
[(
β˜
(
ψ˜
)
, ψ˜
)]
/n is CAN for E [Y0 (β
∗, ψ∗)] =
E [Y0] , when β
∗ and ψ∗ are identified.
This completes the promised proof of our results in the time-independent
case. The proof in the appendix of the general time-dependent case is not much
more difficult when one proceeds by induction. We conclude no sleight of hand
occured in the proof.
Do Correctly Specified SNMMs for Ym|Xm and SNFTMs for Xm Al-
ways Exist? Perhaps the sleight of hand occurred right at the start, when
we supposed that there exist (β∗, ψ∗) such that assumptions (i) and (ii) hold.
We now prove that no such slight of hand is afoot. Specifically we prove that
there always exist correctly specified SNMMs for Ym|Xm and SNFTMs for Xm.
[This result does not, of course, imply that the particular SNMM and SNFTM
we actually choose to analyze are correct.] We actually prove this result for an
alternative, more intuitive, definition of a SNMM for Ym|Xm and a SNFTM
for Xm and then prove these alternative definitions are logically equivalent to
assumptions (i) and (ii). This is done in this subsection for the special case of
a time-independent exposure and in the Appendix for a general time-varying
exposure.
Consider again, for simplicity, our paradigmatic instance. Write A (0) as A.
Suppose that Y ,Y0, X,X0 are all non-negative continuous random variables with
support on (0,∞) , satisfying the consistency assumption X = X0 and Y = Y0
if A = 0. Let S (x|A) = pr (X > x|A) . Let S0 (x|A) = pr (X0 > x|A) . Let
S−10 (x|A) be the inverse of S0 (x|A) wrt the x argument. Define the function
x†0 (x,A) = S
−1
0 [{S (x|A)} |A] . Substituting 0 for A, we find x
†
0 (x, 0) = x, so
x†0 (X, 0) = X wp1 (33)
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Define X†0 = x
†
0 (X,A) . Then X
†
0 = x
†
0 (X, 0) = X, when A = 0. It is well known
that X†0 = x
†
0 (X,A) and X0 have the same conditional distribution given A.
Define S
(
t|A,X†0 = x
)
= pr
(
Y > t|A,X†0 = x
)
and S0 (t|A,X0 = x) =
pr (Y0 > t|A,X0 = x) . Let S
−1
0 (t|A,X0 = x) be the inverse of S0 (t|A,X0 = x)
wrt the t argument. Let y
†
0 (t, x, A) = S
−1
0
({
S
(
t|A,X†0 = x
)}
|A,X†0 = x
)
and Y
†
0 = y
†
0 (Y,X,A) . Then Y
†
0 |A,X
†
0 = x and Y0|A,X0 = x have the same
conditional distribution. It follows that
(
Y
†
0 , X
†
0
)
|A and (Y0, X0) |A have the
same joint conditional distribution . Thus,
E
[
Y
†
0 |X
†
0 = x,A
]
= E [Y0|X0 = x,A] (34)
Define
γ
†
(A, x) = E
[
Y |X†0 = x,A
]
− E
[
Y
†
0 |X
†
0 = x,A
]
≡ E
[
Y − Y
†
0 |X
†
0 = x,A
]
(35)
The last two displays imply that
E
[
Y − γ
†
(
A,X†0
)
|X†0 = x,A
]
= E [Y0|X0 = x,A] (36)
and
γ
†
(0, X) = 0 wp1 (37)
since, by Y
†
0 = y
†
0 (Y,X,A), Y
†
0 = Y when A = 0.
Here are the alternative definitions of a SNFTM for X0 and a SNMM for
Y0|X0.
Definition a: Let x0 (t, a, ψ) be known function montone increasing in t
for each (a, ψ) satisfying x0 (t, a, ψ) = 1 if a = 0 or ψ = 0.We say x0 (t, a, ψ)
is a correctly specified SNFTM for X0 if there exists ψ
∗ such that X0 (ψ
∗) ≡
x0 (X,A, ψ
∗) equals X†0 with probability one.
Definition b: We say a known function γ (a, x, β) satisfying γ (a, x, β) = 0
if a = 0 or β = 0 is a correctly specified SNMM for Y0|X0 if, for some β
∗,
γ (A,X, β∗) = γ
†
(A,X) with probability 1.
Define Y0 (β
∗, ψ∗) = Y − γ (A,X0 (ψ
∗) , β∗) .
It is obvious from definitions a and b that there always exist correctly spec-
ified SNMMs for Y0|X0 under Definition b and correctly specified SNFTMs for
X0 under definition a since γ
†
(A,X) and x†0 (X,A) are well defined functions
of (F, F0) satisfying γ
†
(0, X) = 0 and x†0 (X, 0) = X with probability one,
where F and F0, respectively, denote the joint distribution of (Y,X,A) and
of (Y0, X0, A). Note γ
†
(A,X) and x†0 (X,A) do not depend on the conditional
joint distribution of {(Y,X) , (Y0, X0)} given A. This is as desired as this joint is
not non-parametrically identified from data (Y,X,A) even when A is randomly
assigned.
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Thus it only remain to show the logical equivalence of the original and al-
ternative defintions of a SNFTM for X0 and a SNMM for Y0|X0.
The following Lemma shows that the alternative defintions of a SNFTM for
X0 and a SNMM for Y0|X0 imply the previous definitions.
Lemma: Suppose x0 (t, a, ψ) is a correctly specified SNFTM for X0 as
defined in definition a. Then X0 (ψ
∗) |A has the same distribution as X0|A.
Further assume that γ (a, x, β) is a correctly specified SNMM for Y0|X0 as de-
fined in definition b. Then E [Y0 (β
∗, ψ∗) |A,X0 (ψ
∗) = x] = E [Y0|X0 = x,A] .
Proof: The first result follows immediately from X†0 and X0 having the same
conditional distribution given A. The second result follows from
E
[
Y − γ
†
(A, x) |X†0 = x,A
]
= E [Y0|X0 = x,A] .
Finally, the following Lemma shows that the original definitions imply the
alternative definitions.
Lemma: Suppose x0 (t, a, ψ) is montone increasing in t for each (a, ψ)
satisfying x0 (t, a, ψ) = 1 if a = 0 or ψ = 0. Further suppose that X0 (ψ
∗) |A has
the same distribution as X0|A wp1 where X0 (ψ) = x0 (X,A, ψ) . Then X0 (ψ)
is a correctly specified SNFTM for X0 under definition a. In addition, suppose
that γ (a, x, β) is a function satisfying γ (a, x, β) = 0 if a = 0 or β = 0. Suppose
E
[
Y − γ (A, x, β∗) |X† = x,A = a
]
= E [Y0|X0 = x,A = a] for all (x, a) in a set
of probability 1 under the law of (X0, A) . Then, γ (a, x, β) is a correctly specified
SNMM for Y0|X0 under definition b.
Proof: The proof of the first part follows from the well known result that
X†0 = x
†
0 (X,A) is the only function h (X,A) of (X,A) satisfying h (X,A) |A has
the same distribution as X0|A wp1. The second part is proved by showing that
γ† (a, x) is the unique function h (a, x) satisfying E
[
Y − h (A, x) |X† = x,A = a
]
=
E [Y0|X0 = x,A = a] for all (x, a) in a set of probability 1 as in Refs (8,10).
Are γ
†
(a, x),x
†
0 (x, a) , and E [Y0] nonparametrically identified from data
(Y,X,A) under our assumptions? In this subsection, we finally uncover
some slight of hand that provided us with such seemingly magical results. Al-
though we restrict our discussion to the special case of a time-independent ex-
posure, similiar results apply in the general case. Specifically, we will show that
γ
†
(a, x),x
†
0 (x, a) , and E [Y0] are not identified by the distribution of (Y,X,A)
under the RC and CD assumptions. Previously, we saw that γ
†
(a, x),x
†
0 (x, a) ,
andE [Y0] are identified and equal γ (a, x, β
∗) , x0 (x, a, ψ
∗) , and E [Y − γ (A,X, β∗)] ,
respectively when we assume a correctly specified SNFTM x0 (x, a, ψ) for X0
and a SNMM γ (a, x, β) for Y0|X0 whose true parameters ψ
∗ and β∗ are iden-
tified (by g-estimation). It follows that identification of γ
†
(a, x), x
†
0 (x, a) , and
E [Y0] must result from the functional form restrictions encoded in our models
x0 (x, a, ψ) and γ (a, x, β) . It follows that if we make the restrictions imposed
by our models less rigid by adding additional parameters, we can lose identifica-
tion of γ
†
(a, x), x
†
0 (x, a) , and E [Y0] . This loss of identification occurs when, in
an infinite sample size, more than one combination of parameters, say the true
parameters (ψ∗, β∗) and the false parameters (ψ∗∗, β∗∗) , both make the score
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tests in our g-estimation procedures exactly zero for all choices of Qm (β) linear
in Ym (β) and all choices of Q
∗∗
m (β). This loss of identification can be expressed
by saying that the data (even were the sample size infinite) can not be used
to determine whether the true causal quanties are γ (a, x, β∗) , x0 (x, a, ψ
∗) , and
E [Y − γ (A,X, β∗)] versus γ (a, x, β∗∗) , x0 (x, a, ψ
∗∗) , andE [Y − γ (A,X, β∗∗)] .
In contrast, γ
†
(a, x), x
†
0 (x, a) , and E [Y0] are identifed under the compara-
bility assumption that (Y0, X0) is independent of A0 , without any reliance on
the functional form restrictions encoded in our models. However, in contrast
with assumption RC, this comparability assumptions contradicts our substan-
tive knowledge, as it implies no unmeasured confounding by undiagnosed chronic
disease.
The problem of lack of identification under the RC and CD assumptions
has little to do with the question of local rank preservation. Suppose we have
assumed a correctly specified SNFTM x0 (x, a, ψ) for X0 and we do not assume
RP. Suppose in truth RP holds. Nonetheless, a second investigator who as-
sumes the RP version of the SNFTM model gains nothing thereby in regard to
the estimation of x
†
0 (x, a): the causal quantity x
†
0 (x, a) is identified under the
non-rank preserving SNFTM if and only it is identified under the RP SNFTM.
However, a small amount could be gained by assuming rank preservation for a
SNMM; rarely by assuming RP a non-identifiable SNMM can become identifi-
able as one can then use non-linear functions Qm (β) of Ym (β) in g-estimation.
But this advantage is not actually due to rank preservation. Rather it is due
to the fact that an RP SNMM is actually a special case of a structural nested
distribution model (SNDM) as defined in Refs (5) and (7). Our model SNMM
model γ (a, x, β) for Y0|X0 is a SNDM if Y −γ (A,X, β
∗) is independent (rather
than just mean independent) of A given X. It is this independence (rather than
rank preservation) that licences the use of non-linear functions Qm (β) of Ym (β)
in g-estimation.
Non Identifiability of γ
†
(a, x), x
†
0 (x, a) , and E [Y0] Suppose we do not
impose a SNFTM forX0 or a SNMM for Y0|X0. Then, it is clear that all we can
conclude under assumptions RC and CD is that X
†
0 = x
†
0 (X,A) and A ≡ A (0)
are independent given X
†
0 > ζ and E
[
Y − γ
†
0 (A, x) |A (0) , X
†
0 = x,X
†
0 > ζ
]
=
E
[
Y − γ
†
0 (A, x) |X
†
0 = x,X
†
0 > ζ
]
. As a consequence, our parameter of interest
E [Y0] is not identified. Specifically, under RC and CD, with p = pr (A = 0)
E [Y0] = (38)
E [Y |X > ζ,A = 0 ]
{
pr [X > ζ|A = 0] p+
{
1− pr
[
X† < ζ|A 6= 0
]}}
(1− p)
(39)
+E [Y |X ≤ ζ, A = 0] pr [X ≤ ζ|A = 0] p (40)
+E
[{
Y − γ
† (
A,X†
)}
|X† ≤ ζ, A 6= 0
]
pr
[
X† < ζ|A 6= 0
]
(1− p) . (41)
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However the quantities
pr
[
X† < ζ|A 6= 0
]
= pr [X0 < ζ|A 6= 0] , (42)
E
[{
Y − γ
† (
A,X†
)}
|X† ≤ ζ, A 6= 0
]
= E [Y0|X0 ≤ ζ, A 6= 0] (43)
are not identified under the RC and CD assumptions. It suffices to show this
when RP holds. So, for the moment assume RP. Because both quantities (42)
and (43) refer to the distribution of the counterfactuals responses (Y0, X0) under
no exposure (no weight gain) among those who actually were exposed (A 6= 0) ,
we need an assumption to identify them under RP. But under RC, we only have
comparability conditional on a value of U (0) , which is unknown when X0 < ζ,
so identification fails.
When we additionally assume a SNFTM for X0 and a SNMM for Y0|X0,
we may or may not obtain identification of E [Y0] depending on whether the
additional functional form restrictions encoded in the models suffice to identify
the quantities (42) and (43) by allowing us to extrapolate from X0 > ζ where
we have comparability (since, by CD, U(0) = 0)) to X ≤ ζ where we do not.
To clarify this last statement, consider the following RP SNM for Y0|X0 : Y0 =
Y − γ (A,X0, β
∗) with
γ (A,X0, β) = β0AI (X0 ≤ ζ) + β1AI (X0 > ζ) . (44)
Under assumptions RC and CD, even if we unrealistically suppose that data
on X0 was available for all subjects, we could not identify β
∗ = (β∗0 , β
∗
1 )
T
,
because β∗0 would not be identified, although β
∗
1 would be identified. This
follows from the fact that, under RC and CD, no subject with X0 ≤ ζ may
contribute to g-estimation of β∗. As a consequence we cannot identify E [Y0]
because Y0 = Y −β
∗
0 is not estimable on the subset of exposed subjects (A = 1)
with X0 ≤ ζ.
In contrast, were data on X0 available, β
∗ and E [Y0] are identified in the RP
SNM γ (A,X0, β) = β0A+β1AX0 because both β
∗
0 and β
∗
1 can be estimated by
g-estimation restricted to subects with X0 > ζ. Thus Y0 = Y −β
∗
0A−β
∗
1AX0 can
be estimated for all subjects, including those with A = 1 and X0 ≤ ζ, because,
by having the same parameters apply to subects with X0 ≤ ζ as to subjects with
X0 > ζ, the model allows extrapolation from subjects with X0 > ζ to subjects
with X0 ≤ ζ. One must weigh the benefit of extrapolation that comes with
assuming model γ (A,X0, β) = β0A + β1AX0 against the risk that the model
is misspecified for subjects with X0 ≤ ζ, as would be the case were the true
model: γ (A,X0, β
∗) = β∗0AI (X0 > ζ) + β
∗
1AX0I (X0 > ζ) + β
∗
2AI (X0 ≤ ζ) +
β∗3AX0I (X0 ≤ ζ) with β
∗
2 very different from β
∗
0 and with β
∗
3 very different
from β∗1 . Then the extrapolated value Y − β
∗
0A − β
∗
1AX0 for Y0 based on the
misspecified model would be a badly biased estimate of the true Y0 for subjects
with A = 1 and X0 ≤ ζ. Yet, because the model γ (A,X0, β) = β0A + β1AX0
is correct for subjects with X0 > ζ, there exists no valid test of model fit that
could detect the biased extrapolation when we only assume RC and CD.
Suppose now, as is true in practice, data on X0 are unavailable for subjects
with A = 1. Then, under assumptions, RC and CD, without the help of a correct
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RP SNFTM for X0 whose functional form provides for extrapolation, we can
no longer identify any aspect of the distribution of Y0 for any identifiable subset
of subjects with A 6= 0. This is because, although we know that the identified
quantity E [Y |X > ζ,A = 0 ] equals E [Y0|X0 > ζ,A 6= 0 ] , we cannot identify
which subjects with A 6= 0 have X0 > ζ.
In summary, in the realistic setting of longitudinal time -dependent expo-
sures, the possibility of sensitivity of one’s estimate of E [Y0] to model extrapo-
lation should be examined by reestimating E [Y0] under a variety of models that
differ in both the dimension of the parameter vectors and in functional form.
A final point is that no individual who has developed a chronic disease by
time m is included in our g-estimation procedure at m because Xm (ψ) = X <
m+ς for such subjects. Thus our estimate of the effect of exposure at time m on
a subject with a chronic disease at m is identified wholly by extrapolation from
the effect on subjects without chronic disease at m. One approach to lessening
the degree of extrapolation is to require a subject to be rather ill before they
meet the definition of having a diagnosed chronic disease. For example, mild to
moderate diabetes or hypertension need not qualify as having a chronic disease,
especially if regular data on blood pressure and blood glucose have been recorded
in the data base, as unmeasured confounding by undiagnosed mild to moderate
diabetes or hypertension should then be minimal. If our definition of a diagnosed
chronic disease is sufficiently stringent, then few subjects who meet the definition
atm will be observed to gain weight subsequent to m. In that case, model-based
extrapolation must be minimal - any model-based extrapolation is restricted to
those gaining weight at m, because our models are models for the causal effect
of weight gain (not loss) at m. In Section 3.3 we offer a different appproach to
lessening our reliance on model misspecification.
3.2.5 Can we replace Xm by X Revisited:
We revisit the issue of whether we could have replaced Xm by the observed
X in the CD assumption if we are willing to assume a SNFTM for Xm so
as to link the distribution of X with that of Xm. We take the observed data
to be
(
A (K) , L (K + 1) , Y,X
)
. We will study the implications of 2 different
SNFTMs. The first SNFTM is the model discussed above that assumesXm (ψ
∗)
and Xm have the same conditional distribution given
(
L(m), A(m)
)
. The sec-
ond assumes Xm (ψ
∗) and Xm have the same conditional distribution given(
L(m), A(m), U (m) = 0
)
. In both cases Xm (ψ) is defined by Eqs (28)− (29) .
Note a locally RP SNFTM implies Xm (ψ
∗) = Xm and thus both models are
true. When rank preservation does not hold, the truth of one model does not
imply the truth of the other. We first show that when rank preservation does
not hold, under the RC assumption and the modified CD assumption in which
Xm is replaced by the observed X , the parameter ψ
∗ of the first SNFTM may
not be identifiable; however, the parameter of the second model is estimable
by g-estimation. Thus one might assume we might impose the modified CD
assumption and the second model in lieu of the unmodified CD assumption and
the first model. However we shall see this approach has a drawback: knowledge
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of the parameter ψ∗ of the second model in contrast to that of the first model
does not help identify the parameter of interest E [Y0] .
We now show that ψ∗ is identifiable in the second SNFTM model under RC
assumption and the modified CD assumption. Note X > ζ +m is equivalent to
Xm (ψ) = m+
∫X
m
exp
{
ω
(
A (t) , L (t) , ψ
)}
dt > m+
∫ ζ+m
m
exp
{
ω
(
A (t) , L (t) , ψ
)}
dt.
Thus, the modified CD assumption implies that whenever Xm (ψ) ≥ m +∫ ζ+m
m
exp
{
ω
(
A (t) , L (t) , ψ
)}
dt, we have U (m) = 0. However, even if we made
the the rank preservation assumption that Xm (ψ
∗) = Xm, we cannot therefore
conclude from the RC assumption that A (m) is independent of Xm (ψ
∗) given(
L(m), A(m), Xm (ψ
∗) ≥ m+
∫ ζ+m
m
exp
{
ω
(
A (t) , L (t) , ψ
)}
dt
)
; although this
conditioning event indeed implies U (m) = 0, nonetheless, the conditioning event
also depends on A (t) for t > m, while the conditioning events in the RC as-
sumption do not.
However, if we let d (m,ψ, ζ) be the maximum value of Xm (ψ) among all
subjects with m < X < ζ + m (i.e., subjects with m < Xm (ψ) < m +∫ ζ+m
m
exp
{
ω
(
A (t) , L (t) , ψ
)}
dt), then Xm (ψ) > d (m,ψ, ζ) implies X > ζ+m
and thus U (m) = 0. Thus, we can conclude from the RC assumption that,
under a rank preserving model, A (m) and Xm (ψ
∗) are independent given(
L(m), A(m), Xm (ψ
∗) ≥ d (m,ψ∗, ζ)
)
, since d (m,ψ, ζ) does not vary among
the subjects. (Technically, this independence only holds if we replace d (m,ψ, ζ)
by its probability limit. But this distinction is unimportant for inference be-
cause d (m,ψ, ζ) converges to its probability limit at a rate even faster than n1/2
under mild regularity conditions.) Thus, given a rank preserving SNFTM, we
can use g-estimation to obtain a CAN estimate ψ˜ of ψ∗ under the RC and mod-
ified CD assumption. Specifically, ψ˜ is the ψ for which the 5 degree of freedom
score test of the hypothesis θ = 0 is precisely zero in the model
E
[
A (m) |L(m), A(m− 1),Ξ (m) = 1, Xm (ψ) , Xm (ψ) > d (m,ψ, ζ)
]
= αTW (m) + θTQ∗∗m (ψ) .
Suppose now rank preservation is absent. If we assume the second SNFTM, we
know Xm (ψ
∗) and Xm have the same distribution given L(m), A(m), U (m) =
0. Thus, by the RC assumption A (m) and Xm (ψ
∗) are independent given(
L(m), A(m), Xm (ψ
∗) ≥ d (m,ψ∗, ζ)
)
, U (m) = 0. Hence A (m) and Xm (ψ
∗)
are independent given
(
L(m), A(m), Xm (ψ
∗) ≥ d (m,ψ∗, ζ)
)
since the event
L(m), A(m), Xm (ψ
∗) > d (m,ψ∗, ζ) is equivalent to the event L(m), A(m), Xm (ψ
∗) >
d (m,ψ∗, ζ) , U (m) = 0. So ψ˜ generally remains CAN for ψ∗.
We next show that ψ∗ is not identifiable in the first SNFTM model under
RC assumption and the modified CD assumption. Under the first SNFTM,
we only know Xm (ψ
∗) and Xm have the same distribution given L(m), A(m).
Thus Xm (ψ
∗) |L(m), A(m), Xm (ψ
∗) > d (m,ψ∗, ζ) has the same distribution as
Xm|L(m), A(m), Xm > d (m,ψ
∗, ζ) .
Thus, by equivalence of the conditioning events, bothXm (ψ
∗) |L(m), A(m), Xm (ψ
∗) >
d (m,ψ∗, ζ) and Xm (ψ
∗) |L(m), A(m), Xm (ψ
∗) > d (m,ψ∗, ζ) , U (m) = 0 have
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the same distribution as Xm|L(m), A(m), Xm > d (m,ψ
∗, ζ). However, under
the first SNFTM and without rank preservation, this equality does not allow us
to invoke the RC assumption, since the the conditioning event L(m), A(m), Xm >
d (m,ψ∗, ζ) , U (m) = 0 in that assumption differs from the conditioning event
L(m), A(m), Xm > d (m,ψ
∗, ζ) . Thus we cannot conclude A (m) and Xm (ψ
∗)
are independent given
(
L(m), A(m), Xm (ψ
∗) ≥ d (m,ψ∗, ζ)
)
and so ψ˜ will not
be CAN for ψ∗ under the first SNFTM. Indeed indentification is not possible.
Finally we argue that knowledge of the parameter ψ∗ of the second model
in contrast to that of the first model does not help identify E [Y0]. Under the
second model, we only learn the causal effect of treatment at time m among
those with U(m) = 0. This does not allow us to estimate the distributions of Xm
and thus Ym for all subjects. In fact, the counterfactual distribution of Xm and
thus Ym are not even identified in those with U (m) = 0 for m < K, because the
distributions of XK and thus YK are not identifiable in those with U (m) = 0
but U (K) 6= 0. One way to understand the difference is that the second model
does not allow for the extensive model-based extrapolation that the first model
does. Whether that is viewed as a drawback of the second model clearly depends
on one’s faith in versus skepticism about model-based extrapolation.
3.3 Intractable Confounding In Subgroups:
Our comparability assumption RC that A (m) is statistically independent of
(Ym, Xm) given both L(m) and U (m) = 0 (m) at time m may not be reason-
able for particular, identifiable subgroups of the study population. That is, there
may be identifable subgroups in whom confounding by unmeasured factors is
intractable, where, by defintion, a subgroup is identifable at time m if member-
ship in the subgroup is determined by the measured variables L (m). In Section
2.2.3, we noted that possible examples of such subgroups include subjects with
a diagnosed chronic disease, an age of greater than 70, or a BMI below 21. In
fact, since we have assumed U (m) = 1 whenever X < m, we have all along
been assuming intractable confounding in the identifiable subgroup consisting
of those alive with a diagnosed chronic disease at m (X < m,T > m) .We have
therefore been excluding them from our g-estimation procedure by requiring
Xm > m+ ς for inclusion. Recall that if X < m, then X = Xm.
Suppose therefore we wish to conduct an analysis where no comparability
assumption (neither CO nor RC) is assumed at time m for subjects who, at m,
have an age of greater than 70, or a BMI below 21. To do so, as described in Ref.
(16), we simply redefine Ξ (m) to be zero for such subjects regardless of whether
or not their BMI (m+ 1) ≥ BMImax (m), so that they too are excluded from
contributing to g-estimation at time m. In so doing, we do not change the mod-
els being fit, the interventions under consideration, or the parameter of interest
E [Y0] . Rather we only change, by decreasing, the number of person-time ob-
servations used to estimate our model parameters. We thereby sacrifice some
power and efficiency. As a consequence, even were willing to make assumption
CO for the remaining subjects with Ξ (m) = 1, E [Y0] would no longer be non-
parametrically identified, because model-based extrapolation is now being used
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for identification.
In contrast to g-estimation of SNMs, when confounding by unmeasured fac-
tors is present in certain subgroups of the study population, neither IPTW esti-
mation nor the parametric g-formula estimator can be used to estimate E [Y0] .
If a substantial fraction of the total person time is accrued by subjects in
identifiable subgroups with intractable confounding then either identification
will fail or, more often, the validity of one’s estimate of E [Y0] will rely heavily
on model extrapolation. One, albeit not altogether satisfactory, way to decrease
the reliance on model extrapolation is to give up the attempt to estimate the
parameter of interest E [Y0] . Instead, let IN (m) be the indicator of intractable
confounding in identifiable subgroups that takes the value 1 if at time m a sub-
ject is in an identifiable subgroup with intractable confounding and 0 otherwise.
Note that, based on the above discussion, subjects alive at m with X < m have
IN (m) = 1.
Define Y
⊺
m to be one’s counterfactual outcome when following the time
m⊺dietary intervention in which a subjects follows his observed diet up through
month m and is thereafter weighed daily. On any day in month k > m that
his weight exceeds his previous maximum monthly weight, the subject’s caloric
intake is restricted whenever IN (k) = 0. However, during months in which a
subject is in an intractable subgroup [IN (k) = 1], we place no restrictions on
his diet or weight gain, reflecting the fact that due to intractible confounding,
we are unable to estimate the effect of preventing weight gain among subjects
with IN (m) = 1, except by model extrapolation.
Our new goal becomes to estimate E
[
Y
⊺
0
]
, the mean utility under an inter-
vention in which, starting at age 18, each time m a subject with IN (m) = 0
exceeds his past maximum past BMI, we calorie restrict him to prevent further
weight gain. To estimate E
[
Y
⊺
0
]
by g-estimation we proceed exactly as above
except (i) we define new variables A⊺ (m) and Ξ⊺ (m) that equal A (m) and
Ξ (m) whenever IN (m) = 0 but are zero whenever IN (m) = 1, and (ii) every-
where replace A (m) and Ξ (m) in our g-estimation procedure by A⊺ (m) and
Ξ⊺ (m) . Then, our algorithm that had estimated E [Y0] will now output an esti-
mator of E
[
Y
⊺
0
]
. In summary, at the cost of estimating a parameter E
[
Y
⊺
0
]
of
lesser interest than E [Y0] , we have eliminated the model extrapolation required
to estimate the effect of weight gain among subjects with IN (m) = 1.
However, the procedure in the preceding paragraph has not eliminated the
model extrapolation required to estimate the effect of weight gain among the in-
tractably confounded nonidentifiable subgroup defined by m < Xm < m+ ς . As
a consequence E
[
Y
⊺
0
]
, like E [Y0] , fails to be nonparametrically identified and
must rely on model extrapolation for identification. Specifically the subgroup
with m < Xm < m+ ς is intractably confounded by U (m) . It is not identifiable
because the observed data cannot determine membership. For example, among
subjects with A⊺ (m) > 0, we cannot determine if a subject with X observed to
be between m and m + ς is a subject with m < Xm < m + ς versus a subject
with Xm > m+ ς, with X occurring before m+ ς owing to the causal effect of
his weight gain A⊺ (m) . As a consequence it is not possible to assign all mem-
bers of the intractably confounded subgroup with m < Xm < m + ς the value
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IN (m) = 1, while assigning all members of the unconfounded subgroup with
m+ ς < Xm the value IN (m) = 0. The latter subgroup is unconfounded under
the RC assumption because m + ς < Xm implies U (m) = 0 (m) by the CD
assumption.
In fact, a minimal latent period with length χ > ς is required for nonpara-
metric identification of E
[
Y
⊺
0
]
. For the remainder of this subsection, assume
such a MLP. Then subjects with m < Xm < m + ς form an identifiable sub-
group, as m < X < m + ς and m < Xm < m + ς are equivalent. Similiarly
subjects with Xm > m+ ς now form an identifiable subgroup. Thus we can now
assign IN (m) = 1 to all subjects in the confounded subgroup m < Xm < m+ ς
and IN (m) = 0 to all members of the subgroup Xm > m + ς who were not
already known to have IN (m) = 1 by virtue of membership in some other
intractably confounded subgroup (eg age greater than 70.) Once we have as-
signed all members of the subgroupm < Xm < m+ς the value IN (m) = 1, our
time m⊺ dietary interventions no longer restrict the diet of any subject of any
intractably confounded subgroup. As a consequence E
[
Y
⊺
0
]
is now nonpara-
metrically identified. A formal proof is given in the appendix where it is also
shown that, owing to the nonparametric identification, E
[
Y
⊺
0
]
can be estimated
using the parametric g-formula estimator and the IPTW estimator, as well as
by g-estimation of structural nested models.
4 Censoring:
We now consider the realistic setting in which the available data are O =
A (K) , L (K + 1) , Y,XI (X ≤ K + 1) indicating that X is not observed in sub-
jects for whom X exceeds the end of follow up time K + 1. For such censored
subjects, Xm (ψ) is not observed. As a consequence g-estimation as described
above cannot be done. We will describe a modified estimation procedure that
can be validly applied to censored data. In the interest of brevity, we only con-
sider a procedure that is easy to describe. The down side is that the procedure
we describe is not as efficient as other more complex procedures.
Given a SNFTM for X0 we can still use g-estimation to obtain CAN esti-
mates ψ˜ of ψ∗ from censored data by everywhere replacing Xm (ψ) by Cm (ψ) =
min (Xm (ψ) ,Km (ψ)) , in the g-estimation procedure, where
Km (ψ) = m+ min
{i;Xi>K+1}
{∫ K+1
m
exp
{
ω
(
Ai (t) , Li (t) , ψ
)}
dt
}
(45)
is the smallest possible value ofXm (ψ) any censored subject could possibly have
(as m+
{∫K
m
exp
{
ω
(
A (t) , L (t) , ψ
)}
dt
}
would be Xm (ψ) for a given censored
subject had he died, unbeknownst to us, immediately after end of follow up.).
Note Cm (ψ) > m + ζ implies Xm (ψ) > m+ ζ so our g-estimation procedures
remain restricted to subjects with U (m) = 0.
Similiarly, given a SNMM model we can still use g-estimation to obtain CAN
estimates β˜
(
ψ˜
)
of ψ∗ from censored data by replacing Xm (ψ) by Cm (ψ) ,
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everywhere in the g-estimation procedure. However there is a subtlety in in-
terpretation. Specifically define the function c†m (x) = min (x,Km (ψ
∗)) , so
c†m (Xm (ψ
∗)) = Cm (ψ) . Define Cm = c
†
m (Xm) . The correct definition of our
SNMM model is
E
[
Ym|A (m) , L(m), A(m− 1), Cm = x
]
(46)
= E
[
Ym (β
∗, ψ∗) |A (m) , L(m), A(m− 1), Cm (ψ) = x
]
(47)
where, now,
Ym (β, ψ) = Y −
K∑
j=m
γm
[
A(j), A (j − 1) , L (j) , Cj (ψ) , β
]
. (48)
We refer to this model as a SNMM model for Ym|Cm. Technical details are
given in the appendix. Finally a CAN estimator of E [Y0] from censored data
is
∑n
i=1 Y0,i
[(
β˜
(
ψ˜
)
, ψ˜
)]
/n as before with β˜
(
ψ˜
)
and ψ˜ as redefined in this
section.
5 Maximum Weight Gain Dietary Intervention
Regimes
We use gm to denote a general maximum weight gain dietary intervention regime
beginning at time m. Mathematically gm is a collection of functions gm ={
gk
[
a¯(k − 1), l¯(k)
]
; k = m, ...,K
}
. Under a regime gm a subject follows his own
observed diet history prior tom and then, forK ≥ k ≥ m, gk
[
a¯(k − 1), l¯(k)
]
is a
non-negative function that specifies the increase in maximum BMI to be allowed
at time k for a subject with past exposure and covariate history
[
a¯(k − 1), l¯(k)
]
.
See the definition in the following paragraph for a precise statement. We use
g as shorthand for a regime g0 beginning at time 0. Note that any regime
g =g0 =
{
gk
[
a¯(k − 1), l¯(k)
]
; k = 0, ...,K
}
is naturally associated with a par-
ticular regime gm : the regime gm =
{
gk
[
a¯(k − 1), l¯(k)
]
; k = m, ...,K
}
where
one follows his oberved diet up till time m and then follows regime gm using
functions gk
[
a¯(k − 1), l¯(k)
]
specified by g for k ≥ m. Therefore, we can define
the following counterfactuals.
Let Y gm be a subject’s utility measured at the end of follow-up when the coun-
terfactual intervention gm is followed. Similiarly, letBMI
g
m (k) , L
g
m(k), BMI
g
m,max (k) ,
A
g
m(k) be a subject’s BMI, covariate, maximum BMI and A− history through
k under gm. Note BMI
g
m (k) ∈ L
g
m(k). Then we have the following formal
definition.
Definition of a general time m maximum weight gain dietary in-
tervention regime gm: The subject follows his observed diet up to time
m and from month m onwards, the subject is weighed every day: (i) if A (m) =
BMI (m+ 1)−BMImax (m) ≥ gm
[
A(k − 1), L(k)
]
, the subject’s caloric intake
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is restricted until the subject’s BMI falls to belowBMImax (m)+gm
[
A(k − 1), L(k)
]
;
(ii) for m+1≤ k ≤ K if (a) Agm(k) ≡ BMI
g
m (k + 1) − BMI
g
m,max (k) ≥
gk
[
Agm(k − 1), L
g
m(k)
]
, the subject’s caloric intake is restricted until the sub-
ject’s BMI falls to below BMIgm,max (k)+gk
[
A
g
m(k − 1), L
g
m(k)
]
; (b) if his BMI
is less than BMIgm,max (k) + gk
[
Agm(k − 1), L
g
m(k)
]
, the subject is allowed to
eat as he pleases without any intervention.
Note, by definition, L
g
m(k) equals Lm(k) and A
g
m(k − 1) equals Am(k − 1)
for k ≤ m. Furthermore, given a regime g =g0, we say a subject’s observed data
is consistent with following the associated regime gm if and only if A
g
m(k) ≤
gk
[
A¯gm(k − 1), L
g
m(k)
]
for k ≥ m. It follows that if a subject’s observed data
is consistent with following the associated regime gm, then subject’s observed
data is consistent with following the associated regime gk for any k > m.
If for all k ≥ m, gk
[
a¯(k − 1), l¯(k)
]
is a constant a (k) that does not depend on(
a¯(k − 1), l¯(k)
)
, the regime gm is said to be non-dynamic or static and is writ-
ten gm =a(m) . Otherwise it is dynamic. An intervention that allowed a BMI
gain of 0.1/12 per month (i.e., of 1 per decade) starting at time 0 (age 18) is the
regime g0 =a(0) with each a (m) = 0.1/12. A dynamic intervention starting at
time 0 that allows a BMI gain of 0.1/12 per month in subjects free of hyperten-
sion, diabetes, hyperlipidemia, or clinical CHD, but of only 0.05/12 per month
once a subject developed one of these risk factors is a dynamic regime g0 with
has gk
[
a¯(k − 1), l¯(k)
]
=0.1/12 if l¯(k) indicates a subject is free at k of hyperten-
sion, diabetes, hyperlipidemia, or clinical CHD and gk
[
a¯(k − 1), l¯(k)
]
= .05/12
otherwise.
The expected value E [Y g0 ] is our parameter of interest associated with the
regime g: the expected utility had we placed in 1950 all 18 year old non-smoking
American men on the maximum weight gain intervention regime g.
Let ⌊t⌋ denote the smallest integer less than or equal to t and define b+ = b
if b ≥ 0 and b+ = 0 if b < 0. Note because data is only obtained monthly, for any
non-negative real number t, A (t) = A(⌊t⌋) and L (t) = L(⌊t⌋). Given a regime
g, let Ag∆ (t) =
[
A(⌊t⌋)− g⌊t⌋
[
A(⌊t⌋ − 1), L (⌊t⌋)
]]
+
=
[
BMI (⌊t⌋+ 1)−
{
BMImax (⌊t⌋) + g⌊t⌋
[
A(⌊t⌋ − 1), L (⌊t⌋)
]}]
+
soAg∆ (t) =
0 for all t if and only if a subject’s observed data is consistent with following
regime g from time 0. When Ag∆ (t) 6= 0, A
g
∆ (t) measures how much greater
one’s observed weight gain is than the maximum prescribed by g. Define
Xgm (ψ) = m+
∫ X
m
exp
{
ω
(
Ag∆ (t) , A
(
t−
)
, L (t) , ψ
)}
dt if X > m (49)
Xgm (ψ) = X if X ≤ m (50)
Y gj (β, ψ) = Y −
K∑
m=j
γm
[
Ag∆(m), A (m− 1) , L (m) , Xm (ψ) , β
]
(51)
where the functions ω
(
a (t) , a (t−) , l (t) , ψ
)
and γm
(
a (m) , a (m− 1) , l (m) , ψ
)
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are again known functions satisfying ω
(
a (t) , a (t−) , l (t) , ψ
)
= 0 if a (t) = 0 or
ψ = 0 and γm
(
a (m) , a (m− 1) , l (m) , β
)
= 0 if a (m) = 0 or β = 0.
Given a regime g, we say that (49)-(50) is a correctly specified SNFTM for
Xgm and (51) is a correctly specified SNMM for Y
g
m|X
g
m with true parameters
(β∗, ψ∗) when there exists some (β∗, ψ∗) such that, for each m,
Assumption (i): Xgm and X
g
m (ψ
∗) have the same conditional distribution
given
(
Ag∆(j), A (j − 1) , L (j)
)
and
Assumption (ii):
E
[
Y gm|A
g
∆(m), A(m− 1), L (m) , X
g
m = x
]
= E
[
Y gm (β
∗, ψ∗) |Ag∆(m), A(m− 1), L (m) , X
g
m (ψ
∗) = x
]
(52)
Recall A(m − 1) is a function of L (m) and thus its appearance in the con-
ditioning event is redundant. Define
Ξg (m) = 1⇔ BMI (m+ 1) ≥ BMImax (m) + gm
[
A(m− 1), L (m)
]
(53)
so Ag∆(m) > 0 implies Ξ
g (m) = 1.
Given a regime g, let the RCg assumption be the RC assumption but with
Xgm, Y
g
m,Ξ
g (m) replacing their counterparts without g and Ag∆ replacing A. Let
CDg be the CD assumption but with Xgm replacing Xm and ”time m dietary
intervention” replaced by the ”gm dietary intervention”. Henceforth we assume
the CDg and the RCg hold for all regimes g.
Suppose we carry out g-estimation as in section 3 except withXgm (ψ) , Y
g
m (β, ψ) ,Ξ
g (m)
replacing replacing their counterparts without g and Ag∆ replacing A. Then re-
sults of Robins (4) imply that, under the RCg and CDg assumptions, if the
model
E
[
Ag∆|L(m), A (m− 1) ,Ξ
g (m) = 1
]
= αTW (m)
is correct, and our SNFTM for Xgm and SNMM for Y
g
m|X
g
m are correctly speci-
fied, then ψ˜, β˜
(
ψ˜
)
, and n−1
∑n
i Y
g
0
[(
β˜
(
ψ˜
)
, ψ˜
)]
are CAN for ψ∗, β∗, and the
parameter of interest E [Y g0 ] respectively, provided (β
∗, ψ∗) are identified and
we choose Qm (β) linear in Ym (β) .
6 Measurement Error
In studies of the effect of a time-independent exposure, random exposure mea-
surement error generally leads to bias towards the null and loss of power. How-
ever, the consequences of random exposure measurement error are much more
complex in longitudinal studies of a time-dependent exposure in the prescence
of time- varying counfounders. Specifically, in such a study, exposure history
prior to time t needs to be considered as a potential confounder for the effect
of exposure at t, even under the sharp null hypothesis of no causal effect of
exposure at any time on the outcome Y . Since random measurement error in a
confounder can cause bias in any direction, random error in recorded BMI can,
in principle, cause bias even under the null! See Ref (6). Futhermore this ran-
dom error should be seen as including not only errrors in measurement of BMI
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but also short term flucuations in BMI due to illness, a New Years resolution to
loose weight, etc. These random fluctuations in BMI may have little effect on
eventual mortality, but they can easily obscure the actual trend in someone’s
BMI for periods of up to a year. Thus if we use a monthly scale of analysis
as described above, the random fluctuations in BMI may dominate any trend
within a subject. Further given that past BMI must be controlled for in the
regression models for current BMI used in g-estimation, the true correlation be-
tween past and present BMI trends within a person will be obscured by random
fluctuations, which can even result in bias away from the null. This can occur
when the confounding effect of past trends in BMI are inadequately controlled
due to the random mismeasurement in past BMI. What to do?
One approach would be to specify a complex statistical model for the rela-
tionship between true and mismeasured BMI. At present. I tend to seriously
doubt the robustness of such an approach owing to inevitable model mispecifi-
cation.
The alternative is to increase the ”time” between measurements used in the
analysis from say 1 month up to as high as 5-6 years. By increasing the time
between measurements, the problem of random fluctuations in BMI is markedly
reduced, as the BMI signal (the true difference betwen measurement occassions)
is made much greater, while the random fluctuations may not increase or may
even decrease if the fluctuations are autocorrelated on a time scale of a few
to many months. The drawback of increasing the ”time” between measure-
ments in the analysis is that this can lead to poorer control of the confounding
attributable to evolving time-varying factors. As an example, because the tem-
poral ordering of events between the measurement times used in the analysis is
lost; the confounding effect of changes in exercise may be incorrectly attributed
to a causal effect of BMI.
At present I would recommend repeating one’s analysis using a number of
different between measurements ”times” and report all results. In this way, the
sensitivity of one’s conclusions to the choice of the ”time” between measurements
will be known. If important, this sensitivity will stimulate further discusion and
the development of better analytic methods.
7 Appendix 1:
7.1 A Formal Definition of a Joint SNFTM for Xm and a
SNMM for Ym|Xm
The definition here is the alternative, more intuitive and more general definition
mentioned in the main text. The equivalence with the definitions in the main
text are proved below.
We first consider the uncensored case. The observed data isO = A (K) , L (K + 1) , X, Y,
where X is a continuous time to event variable and Y is measured at K + 1.
The counterfactual data are (Xm, Ym) , m=0,...,K+1, denoting X and Y under
treatment regimes where one experiences his observed treatment A (m− 1) up
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to m and then receives no treatment (treatment level 0) thereafter. We make
the assumption that XK+1 = X,YK+1 = Y. The covariate L (k) precedes A (k)
which precedes L (k + 1) .
The function x†m
(
x, L (m) , A (m)
)
= S−1
Xm|L(m),A(m)
{
SXm+1|L(m),A(m) (x)
}
is a counterfactual conditional quantile -quantile function, where S and S−1 de-
note a survivor function and its inverse. It is a standard result that x†m
(
x, L (m) , A (m)
)
is the unique function for which X∗m ≡ x
†
m
(
Xm+1, L (m) , A (m)
)
and Xm have
the same conditional distribution, i.e.,
X∗m|L (m) , A (m) ˜Xm|L (m) , A (m) (54)
DefineX†K+1 = X and then recursively defineX
†
m = x
†
m
(
X†m+1, L (m) , A (m)
)
.
Robins and Wasseman (7) proved the following
Theorem A1:
Xm|L (m) , A (m) ˜X
†
m|L (m) , A (m) (55)
where we silently take such displays to hold for all m=0,...,K.
Furthermore, Robins (8,10) and Lok (9) proved the function x†m is unique.
That is if the above display holds for withX†m replaced by someHm = hm
(
Hm+1, L (m) , A (m)
)
and HK+1 = X, then the function hm must be the function x
†
m.
A SNFTM for Xm assumes
xm
(
Xm+1, L (m) , A (m) ;ψ
∗
)
= x†m
(
Xm+1, L (m) , A (m)
)
(56)
for a known function xm
(
x, L (m) , A (m) ;ψ
)
satisfying xm
(
x, L (m) , A (m) , ψ
)
=
x if ψ = 0 or A (m) = 0 with ψ
∗
an unknown parameter vector.
It follows immediately that
Xm
(
ψ
∗
)
|L (m) , A (m) ˜X†m|L (m) , A (m) , (57)
with XK+1
(
ψ
∗
)
= X and Xm
(
ψ
∗
)
≡ xm
(
Xm+1
(
ψ
∗
)
, L (m) , A (m) ;ψ
∗
)
(58)
The uniqueness of x†m implies that SNFTMs as defined in the text are also
SNFTMs as defined here.
Recall X∗m ≡ x
†
m
(
Xm+1, L (m) , A (m)
)
and define
γ†m
(
A (m) , L (m) , x
)
≡ E
[
Ym+1|A (m) , L (m) , X
∗
m = x
]
−E
[
Ym|A (m) , L (m) , Xm = x
]
(59)
which is equivalent to
E
[
Ym+1 − γ
†
m
(
A (m) , L (m) , X∗m
)
|A (m) , L (m) , X∗m = x
]
= E
[
Ym|A (m) , L (m) , Xm = x
]
.
(60)
Define Y †K+1 = Y and then recursively define Y
†
m = Y
†
m+1−γ
†
m
(
A (m) , L (m) , X†m
)
.
42
Below we prove the following theorem.
Theorem A2:
E
[
Y †m|L (m) , A (m) , X
†
m = x
]
= E
[
Ym|L (m) , A (m) , Xm = x
]
(61)
Furthermore the function γ†m is unique. That is if the above display holds
with Y †m replaced by some Hm = Hm+1−hm
(
A (m) , L (m) , X†m
)
and HK+1 =
Y, then the function hm must be the function γ
†
m.
An additive SNMM for Ym|Xm assumes
γm
(
A (m) , L (m) , x;β
∗
)
= γ†m
(
A (m) , L (m) , x
)
(62)
for a known function γm
(
A (m) , L (m) , x;β
)
satisfying γm
(
A (m) , L (m) , x;β
)
=
0 if β = 0 or A (m) = 0 with β∗ an unknown parameter vector.
It follows immediately that
E
[
Ym
(
β
∗
, ψ
∗
)
|L (m) , A (m) , Xm
(
ψ
∗
)
= x
]
= E
[
Ym|L (m) , A (m) , Xm = x
]
,
(63)
with YK+1
(
β
∗
, ψ
∗
)
= Y and Ym
(
β
∗
, ψ
∗
)
≡ Ym+1
(
β
∗
, ψ
∗
)
− γm
(
A (m) , L (m) , Xm
(
ψ
∗
)
;β
∗
)
(64)
The uniqueness of γ†m implies that an additive SNMM for Ym|Xm as defined
in the text is equivalent to the additive SNMM for Ym|Xm as defined here.
Proof of Theorem A2: By backward induction.
Case 1:m=K; E
[
Y †K |L (K) , A (K) , X
†
K = x
]
=E
[
YK+1 − γ
†
K
(
A (K) , L (K) , X∗K
)
|A (K) , L (K) , X†K = x
]
=E
[
YK+1 − γ
†
K
(
A (K) , L (K) , X∗K
)
|A (K) , L (K) , X∗K = x
]
= E
[
YK |A (K) , L (K) , XK = x
]
where the first equality uses the definition of Y †K and that YK+1 = Y = Y
†
K+1,
the second uses that X∗K = X
†
K by XK+1 = X = X
†
K+1, and the third is the
definition of γ†K
(
A (K) , L (K) , X∗K
)
.
Case 2: Assume true for m. We prove true for m+1.
We will require the following Lemma
Lemma:
f
(
L (m+ 1) , A (m+ 1) |L (m) , A (m) , X†m = x
)
= f
(
L (m+ 1) , A (m+ 1) |L (m) , A (m) , X∗m = x
)
Proof: f
(
L (m+ 1) , A (m+ 1) |L (m) , A (m) , X†m = x
)
=
{
f
(
X†m = x|L (m) , A (m)
)}−1
f
(
L (m+ 1) , A (m+ 1) , X†m = x|L (m) , A (m)
)
=
{
f
(
X∗m = x|L (m) , A (m)
)}−1
×
∂x†−1m (x,L(m),A(m))
∂x f
(
L (m+ 1) , A (m+ 1) , X†m+1 = x
†−1
m
(
x, L (m) , A (m)
)
|L (m) , A (m)
)
=
{
f
(
X∗m = x|L (m) , A (m)
)}−1
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∂x†−1m (x,L(m),A(m))
∂x f
(
L (m+ 1) , A (m+ 1) , Xm+1 = x
†−1
m
(
x, L (m) , A (m)
)
|L (m) , A (m)
)
=
{
f
(
X∗m = x|L (m) , A (m)
)}−1
f
(
L (m+ 1) , A (m+ 1) , X∗m = x|L (m) , A (m)
)
=f
(
L (m+ 1) , A (m+ 1) |L (m) , A (m) , X†m = x
)
where the first equality is by Bayes rule, the second byX∗m andX
†
m both hav-
ing the same law as Xm conditional on L (m) , A (m) and a change of variables
fromX†m toX
†
m+1, the third by
(
X†m+1, L (m+ 1) , A (m+ 1)
)
and
(
Xm+1, L (m+ 1) , A (m+ 1)
)
having same joint distribution, the fourth by the definition of X∗m and a change
of variables, and the 5th by Bayes rule.
Now to the proof of case 2:
E
[
Y †m|L (m) , A (m) , X
†
m = x
]
= E
[
Y †m+1 − γ
†
m
(
A (m) , L (m) , X†m
)
|L (m) , A (m) , X†m = x
]
=E
{
E
[
Y †m+1|L (m+ 1) , A (m+ 1) , X
†
m|L (m) , A (m) , X
†
m = x
]}
−γ†m
(
A (m) , L (m) , x
)
= E
{
E
[
Y †m+1|L (m+ 1) , A (m+ 1) , X
†
m+1 = x
†−1
m
(
x, L (m) , A (m)
)
|L (m) , A (m) , X†m = x
]}
−γ†m
(
A (m) , L (m) , x
)
=E
{
E
[
Ym+1|L (m+ 1) , A (m+ 1) , Xm+1 = x
†−1
m
(
x, L (m) , A (m)
)]
|L (m) , A (m) , X†m = x
}
−γ†m
(
A (m) , L (m) , x
)
=E
{
E
[
Ym+1|L (m+ 1) , A (m+ 1) , Xm+1 = x
†−1
m
(
x, L (m) , A (m)
)]
|L (m) , A (m) , X∗m = x
}
−γ†m
(
A (m) , L (m) , x
)
=E
{
E
[
Ym+1|L (m+ 1) , A (m+ 1) , X
∗
m = x
]
|L (m) , A (m) , X∗m = x
}
−γ†m
(
A (m) , L (m) , x
)
=E
[
Ym+1|L (m) , A (m) , X
∗
m = x
]
− γ†m
(
A (m) , L (m) , x
)
=E
[
Ym|L (m) , A (m) , Xm = x
]
,
where the first equality is by the definition of Y †m, the second by iterated
expectations, the third by the definiton of X†m, the fourth by the induction
hypothesis, the fifth by the preceding Lemma, the sixth by the definition of
X∗m,the 7th by the laws of probability, and the eighth by the definition of
γ†m
(
A (m) , L (m) , x
)
. Uniqueness is proved as in Refs (4,10) and is omitted.
Additive SNMM for Ym|Xm may not be not appropriate for analyzing cen-
sored data due to adminstrative censoring of X at time K as discussed in the
text. As indicated in Section 4, our approach requires that we consider a broader
class of SNMM models which we now describe.
Consider a collection of functions c†m
(
x,A (m) , L (m)
)
indexed bym and de-
fine C∗m = c
†
m
(
X∗m, A (m) , L (m)
)
, C†m = c
†
m
(
X†m, A (m) , L (m)
)
, Cm = c
†
m
(
Xm, A (m) , L (m)
)
,
and Cm (ψ) = c
†
m
(
Xm, A (m) , L (m) , ψ
)
. For fixed A (m) , L (m) , c†m
(
x,A (m) , L (m)
)
need not be a 1-1 function of x. The approach described in the text for handling
right censoring of X at tiime K +1 amounts to the selection of particular func-
tions c†m that guarantee that Cm (ψ) is an observable (i.e. uncensored) random
variable.
Let cm denote an arbitrary element in the range of c
†
m. Redefine
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γ†m
(
A (m) , L (m) , cm
)
≡ E
[
Ym+1|A (m) , L (m) , C
∗
m = cm
]
−E
[
Ym|A (m) , L (m) , Cm = cm
]
(65)
which is equivalent to
E
[
Ym+1 − γ
†
m
(
A (m) , L (m) , C∗m
)
|A (m) , L (m) , C∗m = cm
]
= E
[
Ym|A (m) , L (m) , Cm = cm
]
.
(66)
Define Y †K+1 = Y and then recursively redefine Y
†
m = Y
†
m+1−γ
†
m
(
A (m) , L (m) , C†m
)
.
Below we prove the following theorem.
Theorem A3: Suppose, for m = 0, ....,K − 1,
c†m+1
(
x,A (m+ 1) , L (m+ 1)
)
= dm+1
[
c†m
{
x†m
(
x,A (m) , L (m)
)
, A (m) , L (m)
}
, A (m+ 1) , L (m+ 1)
]
(67)
for some function dm+1
(
cm, A (m+ 1) , L (m+ 1)
)
, where x†m
(
x,A (m) , L (m)
)
is as defined previously. That is, the function c†m+1 = dm+1 ◦ c
†
m ◦ x
†
m. Then
E
[
Y †m|L (m) , A (m) , C
†
m = x
]
= E
[
Ym|L (m) , A (m) , Cm = cm
]
(68)
Furthermore the function γ†m is unique. That is, if the above display holds
with Y †m replaced by some Hm = Hm+1 − hm
(
A (m) , L (m) , C†m
)
and HK+1 =
Y, then the function hm must be the function γ
†
m.
Remark: The need for Eq 67 in the supposition to Theorem A.3 is because
the function c†m
(
x,A (m) , L (m)
)
need not be a 1-1 function of x.
An additive SNMM for Ym|Cm assumes
γm
(
A (m) , L (m) , cm;β
∗
)
= γ†m
(
A (m) , L (m) , cm
)
(69)
for a known function γm
(
A (m) , L (m) , cm;β
)
satisfying γm
(
A (m) , L (m) , cm;β
)
=
0 if β = 0 or A (m) = 0 with β∗ an unknown parameter vector.
It follows immediately that
E
[
Ym
(
β
∗
, ψ
∗
)
|L (m) , A (m) , Cm
(
ψ
∗
)
= x
]
= E
[
Ym|L (m) , A (m) , Cm = x
]
,
(70)
with YK+1
(
β
∗
, ψ
∗
)
= Y and Ym
(
β
∗
, ψ
∗
)
≡ Ym+1
(
β
∗
, ψ
∗
)
− γm
(
A (m) , L (m) , Cm
(
ψ
∗
)
;β
∗
)
(71)
Proof of A.3 : We only describe where the proof differs from that of its special
case Theorem A.2. The proof is essentially identical except for the replacement
of Xm by Cm, x by cm, and x
†−1
m
(
x, L (m) , A (m)
)
by
c†m+1
{
x†−1m
(
c†−1m
(
cm, L (m) , A (m)
)
, L (m) , A (m)
)
, L (m+ 1) , A (m+ 1)
}
(72)
.The only problematic point is that, now, since x†−1m
(
c†−1m
(
cm, L (m) , A (m)
)
, L (m) , A (m)
)
is the subset X
(
cm, L (m) , A (m)
)
=
{
x : c†m
(
x†m
(
x, L (m) , A (m)
)
, L (m) , A (m)
)
= cm
}
of the nonnegative real line, a necessary condition for
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c†m+1
{
x†−1m
(
c†−1m
(
cm, L (m) , A (m)
)
, L (m) , A (m)
)
, L (m+ 1) , A (m+ 1)
}
to
be a well defined function is that every element of the set X
(
cm, L (m) , A (m)
)
has the same image under c†m+1
(
·, L (m+ 1) , A (m+ 1)
)
. The choice
c†m+1
(
·, L (m+ 1) , A (m+ 1)
)
≡ c†m
{
x†m
(
·, A (m) , L (m)
)
, A (m) , L (m)
}
sat-
isfies this constraint with the image being cm itself. More generally, the choice
of c†m+1
(
·, L (m+ 1) , A (m+ 1)
)
given in Eq 67 satisifies the constraint.
8 Appendix 2: Estimation of Effects with the
Parametric G-formula and IPTWWhen a Suf-
ficiently Long Minimal Latent Period Exists:
In this section we show that the the parametric G-formula and IPTW can
be used to estimate certain causal effects when their exists a sufficiently long
minimal latent period. We begin with a preliminary discussion of these two
methods of estimation.
8.1 Preliminaries:
In this preliminary discussion, we assume that, as in Section 3.1.1, there is
neither confounding by pre-clinical disease nor a minimal latent period. Specif-
ically we assume, for each regime g, the COg assumption that, for each j,
(Y g0 , X
g
0 ) ∐ A
g
∆ (j) |L (j) , A
g
∆ (j − 1) = 0 (j − 1) ,Ξ
g (j) = 1 holds, with Ξg (m)
defined in Equation (53).
Recoding: Without loss of generality, we henceforth redefine (ie recode)
L (j) such that Ξg (j) is now one of the components of L (j) but we remove from
L (j) the components corresponding toX, ie the components (XI (X ≤ j) , I (X ≤ j)) .
Then we can write the COg assumption as
COg :
(
Y gj , X
g
j
)
∐Ag∆ (j) |L (j) , A
g
∆ (j − 1) = 0 (j − 1) , (XI (X ≤ j) , I (X ≤ j))
(73)
since, from their definitions, Ξg (j) = 0 implies Ag∆ (j) = 0. The CO
g assumption
implies
(Y g0 , X
g
0 )∐A
g
∆ (j) |L (j) , A
g
∆ (j − 1) = 0 (j − 1) , (XI (X ≤ j) , I (X ≤ j)) (74)
since A
g
∆ (j − 1) = 0 (j − 1) implies
(
Y gj , X
g
j
)
= (Y g0 , X
g
0 ). This last display is
the standard definiton of no unmeasured confounding given
(
L (j) , (XI (X ≤ j) , I (X ≤ j))
)
for the effect ofAg∆ (j) on the counterfactuals Y
g
0 , X
g
0 . Let λ (u|·) = limh→0 pr [u ≤ X < u+ h|·, u ≤ X ] /h
be the conditional hazard of X given ·.
Robins (14,15) proves that Eq 74 implies that SXg0 (u) ≡ pr (X
g
0 > u) is
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identified via
SXg0 (u)
=
∫
· · ·
∫
exp
{
−
∫ u
0
λ
(
t|L (t) , A
g
∆ (t) = 0
)
dt
}
× (75)
m=⌊u⌋∏
m=0
dF
[
L (m) |L (m− 1) , A
g
∆ (m− 1) = 0, X > m
]
= E
[
I {X > u} I
{
A
g
∆ (u) = 0
}
W
g,∗ (u)
]
(76)
with
W
g,∗ (u) = 1/
m=⌊u⌋∏
m=0
pr
[
Ag∆ (m) = 0|L (m) , A
g
∆ (m− 1) , X > m
]
, (77)
where the first formula for SXg0 (u) is referred to as the g-computation algorithm
formula (g-formula, for short) and the second formula as the IPTW formula.
To shorten the formulae we have written 0 as shorthand for 0 (t) when the time
t is clear. In fact Robins (14, 15) shows that the assumption
Xg0 ∐ A
g
∆ (j) |L (j) , A
g
∆ (j − 1) = 0 (j − 1) , X > j, (78)
which is implied by the assumption of Eq (74), suffices to establish the identify-
ing formulae. To estimate SXg0 (u) we can using either the parametric g-formula
estimator that replaces the unknowns λ
(
t|L (t) , A
g
∆ (t) = 0
)
and f
[
L (m) |L (m− 1) , A
g
∆ (m− 1) = 0, X > m
]
in the first formula by estimates based on parametric models or the IPTW esti-
mator that replaces the unknown pr
[
Ag∆ (m) = 0|L (m− 1) , A
g
∆ (m− 1) = 0, X > m
]
in the second formula with a parametric estimate and the unknown expectation
with a sample average. Both approaches are alternatives to g-estimation of
structural nested models.
Robins (14,15) proves E [Y g0 ] is identified under the assumption of Eq (74)
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by
E [Y g0 ] =
∫ K+1
0
dx×∫
· · ·
∫
λX
(
x|L (x) , A
g
∆ (x) = 0
)
exp
{
−
∫ x
0
λX
(
t|L (t) , A
g
∆ (t) = 0
)
dt
}
×
m=⌊x⌋∏
m=0
dF
[
L (m) |L (m− 1) , A
g
∆ (m− 1) = 0, X > m
]
×
K+!∏
m=⌊x+1⌋
dF
[
L (m) |L (m− 1) , A
g
∆ (m− 1) = 0, X = x
]
×
E
[
Y |L (K + 1) , A
g
∆ (K) = 0, X = x
]
= E
[
Y I
{
A
g
∆ (K) = 0
}
W
g,∗
]
with
W
g,∗ = Wg,∗ (X)
1/
K∏
m=⌊X+1⌋
pr
[
Ag∆ (m) = 0|L (m) , A
g
∆ (m− 1) = 0, X,X < m
]
In the above formulae, we have assumed for simplicity that X has support
on (0.K + 1) so censoring for X is absent.
We next consider whether SXg0 (u) and E [Y
g
0 ] remain identified in the pres-
cence of confounding by pre-clinical disease and a sufficiently long minimal latent
period (MLP).
8.2 Identification and Estimation of SXg
0
(u) :
The following theorem establishes the identification of SXg0 (u) . First note under
our recoding, the RCg assumption becomes
RCg :
(
Y gj , X
g
j
)
∐Ag∆ (j) |L (j) , A
g
∆ (j − 1) , U (j) = 0, (XI (X ≤ j) , I (X ≤ j)) ,
(79)
Theorem A4: Given a regime g, let a g-specific MLP satisfy the definition
of a MLP of Sec. 3.2.1 except with Xk and Xm replaced by by X
g
k and X
g
m and
A (m) replaced by Ag∆ (m) . Suppose A
g
∆ (m) has a g−specificMLP of χmonths
for its effect on X where χ exceeds the time ς in the CDg assumption. Then,
under the CDg and RCg assumptions, SXg0 (u) remains identified by both the g-
formula and the IPTW formula when the recoded L (t) and Ag∆ (t) are redefined
as L† (t) and Ag,†∆ (t) where
L† (t) = L (t− χ) , Ag,†∆ (t) = A
g,†
∆ (t− χ) (80)
The theorem thus states that the identifying formulas are the usual g-formula
and IPTW formula except we replace both the treatment variable Ag∆ (t) and
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the covariate variable L† (t) by their values χ time units earlier. [For the IPTW
formula the transformation is applied to Wg,∗ (u) .] It is important to emphasize
that a similiar transformation is not applied to X. Thus the conditioning event
L (m− 1) , A
g
∆ (m− 1) = 0, X > m transforms to L (m− 1− χ) , A
g
∆ (m− 1− χ) =
0, X > m.
Proof of Theorem: It suffices to show Eq. (78) holds when L (t) and Ag∆ (t)
are replaced by L† (t) andAg,†∆ (t) . By RC
g ,
(
Y gj , X
g
j
)
∐Ag∆ (j) |L (j) , A
g
∆ (j − 1) =
0, U (j) = 0, X > j. Thus,
(
Y gj , X
g
j
)
∐ Ag∆ (j) |L (j) , A
g
∆ (j − 1) = 0, U (j) =
0, X > j,Xgj > j+χ. By CD
g and χ > ς,
(
Y gj , X
g
j
)
∐Ag∆ (j) |L (j) , A
g
∆ (j − 1) =
0, Xgj > j + χ,X > j.
Thus
(
Y gm−χ, X
g
m−χ
)
∐ Ag∆ (m− χ) |L (m− χ) , A
g
∆ (m− χ− 1) = 0, X >
(m− χ) , Xgm−χ > m with m ≡ χ+ j.
Now the event X > (m− χ) is the event Xgm−χ > (m− χ) .Further, by χ a
g-specific minimal latent period we also have the event Xgm−χ > m is the event
X > m. Thus we have
(
Y gm−χ, X
g
m−χ
)
∐ Ag∆ (m− χ) |L (m− χ) , A
g
∆ (m− χ) =
0 (m− χ) , X > m. Since, givenA
g
∆ (m− χ) = 0 (m− χ− 1) , we have
(
Y gm−χ, X
g
m−χ
)
=
(Y g0 , X
g
0 ) , we conclude (Y
g
0 , X
g
0 ) ∐ A
g
∆ (m− χ) |L (m− χ) , A
g
∆ (m− χ− 1) =
0 (m− χ) , X > m, which is exactly Eq. (78) with L (t) and Ag∆ (t) replaced by
L† (t) and Ag,†∆ (t) , proving the theorem.
In contrast, under the conditions of the previous theorem, E [Y g0 ] is not
identified because Eq. (74) , in contrast to Eq. (78) , fails to hold when L (t)
and Ag∆ (t) are replaced by L
† (t) and Ag,†∆ (t) . Specifically, Eq. (74) can be
written as the conjunction of Eq (78),
(Y g0 , X
g
0 )∐ A
g
∆ (m) |L (m) , A
g
∆ (m− 1) = 0, X,m > X > m− χ+ ς (81)
and
(Y g0 , X
g
0 )∐ A
g
∆ (m) |L (m) , A
g
∆ (m− 1) = 0, X,m− χ+ ς > X (82)
Below we show that under the conditions of the previous Theorem, Eq.(81)
holds but Eq (82) does not when L (t) and Ag∆ (t) are replaced by L
† (t) and
Ag,†∆ (t) . To show (81) we modify slightly the proof of eq (78) as follows:(
Y gj , X
g
j
)
∐ Ag∆ (j) |L (j) , A
g
∆ (j − 1) = 0, U (j) = 0, X > j (by RC
g)
⇒
(
Y gj , X
g
j
)
∐ Ag∆ (j) |L (j) , A
g
∆ (j − 1) = 0, U (j) = 0, X > j,X
g
j , j + ς <
Xgj < j + χ
⇒
(
Y gj , X
g
j
)
∐ Ag∆ (j) |L (j) , A
g
∆ (j − 1) = 0, X > j,X
g
j , j + ς < X
g
j < j + χ
(by CDg)
⇒
(
Y gm−χ, X
g
m−χ
)
∐Ag∆ (m− χ) |L (m− χ) , A
g
∆ (m− χ− 1) = 0, X > (m− χ) , X
g
m−χ,m >
Xgm−χ > m− χ+ ς.
⇒ (Y g0 , X
g
0 )∐A
g
∆ (m− χ) |L (m− χ) , A
g
∆ (m− χ− 1) = 0, X
g
m−χ > (m− χ) , X
g
m−χ,m >
Xgm−χ > m− χ+ ς
⇒ (Y g0 , X
g
0 ) ∐ A
g
∆ (m− χ) |L (m− χ) , A
g
∆ (m− χ− 1) = 0, X,m > X >
m− χ+ ς by the g − specific MLP assumption.
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The proof of (82) fails because the event L (j) , A
g
∆ (j − 1) = 0, U (j) =
0, X > j,Xgj , X
g
j < j+ ς is not the same event as L (j) , A
g
∆ (j − 1) = 0, U (j) =
0, X > j,Xgj , X
g
j < j + ς under CD
g because Xgj < j + ς does not imply
U (j) = 0.
Proof that E [Y ⊺0 ] is nonparametrically identified when a sufficiently
long MLP exists . In Section 3.3, we stated that E [Y ⊺0 ] is nonparametrically
identified under the conditions of the previous theorem with the regime g in the
theorem being the regime that always assigns exposure zero. A proof follows.
Let IN,A⊺,Ξ⊺, Y ⊺m, X
⊺
m be as defined in Section 3.3 where we recall that
because of the existence of the MLP of length χ > ς, all subjects with ς <
Xm < m + ς have IN (m) = 1. First in Eqs 78, 81, 82 we replace (Y
g
0 , X
g
0 )
by (Y ⊺0 , X
⊺
0 ) , A
g
∆ (m) by A
⊺ (m− χ) , and redefine L (m) as L (m− χ) with the
component Ξ (m) of L (m) being replaced by Ξ⊺ (m− χ) . Eq 82 now holds
trivially because with probability one m − χ + ς > X implies IN (m− χ) = 1
and thus Ξ⊺ (m− χ) = 0 and A⊺ (m− χ) = 0. Furthermore the proofs of Eqs 78
and 81 go through as above with only minor notational changes. We therefore
conclude that Eq 74 holds and thus that E [Y ⊺0 ] is nonparametrically identified.
The identifying IPTW formula is explicitly given by
E [Y ⊺0 ] = E
[
Y I
{
A⊺ (K − χ) = 0
}
W
g,∗
]
,
{Wg,∗}
−1
=
m=⌊X⌋∏
m=0
pr
[
A⊺ (m− χ) = 0|L (m− χ) , A
⊺
(m− χ− 1) = 0, X > m
]
×
K∏
m=⌊X+1⌋
pr
[
A⊺ (m− χ) = 0|L (m− χ) , A
⊺
(m− χ− 1) = 0, X
]
9 Appendix 3: Optimal Regime Models :
Suppose we now wish to estimate the regime gopt that maximizes E [Y
g
0 ] over
all regimes g of the previous subsection. We will do so by specifying an optimal
regime stuctural nested mean model and associated SNFTM.
To begin consider the dietary intervention a (k) , g
opt,k+1
in which one fol-
lows there observed diet up to month k, has a BMI increase of a (k) over there
maximum previous BMI in month k, and follows the unknown optimal regime
gopt thereafter. Let Y
a(k),g
opt,k+1 , X
a(k),g
opt,k+1 be the associated counterfactu-
als. When A (k) = a (k) , write g
opt,k+1
for the regime A (k) , g
opt,k+1
. Note
X
g
opt,K+1 = X.
We will make the following assumptions:
Optimal regime RC Assumption : A (m) is statistically independent of(
Y
a(m),g
opt,m+1 , X
a(m),g
opt,m+1
)
given Ξ (m) = 1, L(m), A (m− 1) and U (m) =
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0 (m) for each a (m) ≥ 0
Optimal Regime CD Assumption:
X
g
opt,m > m+ ζ ⇒ U (m) = 0 (m) (83)
We next recursively define the random variables X
a(m),g
opt,m+1 (ψ) by the
relationship that X
g
opt,K+1 (ψ) = X and, for m = K, ..., 0.
X
0(m),g
opt,m+1 (ψ) = m+ exp
{
ω
(
a (m) , A (m− 1) , L (m) , ψ
)}(
X
a(m),g
opt,m+1 (ψ)−m
)
if 0 < X
a(m),g
opt,m+1 (ψ)−m < 1
X
0(m),g
opt,m+1 (ψ) = X
a(m),g
opt,m+1 (ψ) +
{
exp
{
ω
(
a (m) , A (m− 1) , L (m) , ψ
)}
− 1
}
if 1<X
a(m),g
opt,m+1 (ψ)−m
X
0(m),g
opt,m+1 (ψ) = X
a(m),g
opt,m+1 (ψ)
if X
a(m),g
opt,m+1 (ψ) < m,
These equations recursively defineX
a(m),g
opt,m+1 (ψ) in terms of the observed
data, the regime g
opt,m+1
and the parameter vector ψ as can be verified by noting
that these equations imply the following relationship between X
a(m),g
opt,m+1 (ψ)
and X
g
opt,m+1 (ψ) .
X
a(m),g
opt,m+1 (ψ) = m+
exp
{
ω
(
A (m) , A (m− 1) , L (m) , ψ
)}
exp
{
ω
(
a (m) , A (m− 1) , L (m) , ψ
)} (Xgopt,m+1 (ψ)−m)
if 0 < X
g
opt,m+1 (ψ)−m < 1, 0 < X
a(m),g
opt,m+1 (ψ) < 1
X
a(m),g
opt,m+1 (ψ)
= X
g
opt,m+1 (ψ) + exp
{
ω
(
A (m) , A (m− 1) , L (m) , ψ
)}
− exp
{
ω
(
a (m) , A (m− 1) , L (m) , ψ
)}
if 1<X
a(m),g
opt,m+1 (ψ)−m, 1<X
g
opt,m+1 (ψ)−m
X
a(m),g
opt,m+1 (ψ) = m+ exp
{
ω
(
A (m) , A (m− 1) , L (m) , ψ
)}(
X
g
opt,m+1
m (ψ)−m
)
+1− exp
{
ω
(
a (m) , A (m− 1) , L (m) , ψ
)}
if 0 < X
g
opt,m+1
m (ψ)−m < 1, 1 < X
a(m),g
opt,m+1 (ψ)−m
X
a(m),g
opt,m+1 (ψ) = m+
{[
exp
{
ω
(
A (m) , A (m− 1) , L (m) , ψ
)}
− 1
]
+
(
X
g
opt,m+1 (ψ)−m
)}
exp
{
ω
(
a (m) , A (m− 1) , L (m) , ψ
)}
if 0 < X
a(m),g
opt,m+1 −m (ψ) < 1, 1 < X
g
opt,m+1 −m (ψ)
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We next assume an optimal regime SNFTM given by
X
a(m),g
opt,m+1 (ψ∗) = X
a(m),g
opt,m+1wp1 (84)
for an unknown value ψ∗ of the vector ψ.
We also assume the optimal regime SNMM
γm
[
a (k) , a (m− 1) , l (m) , x, β∗
]
≡ (85)
E
[
Y
a(k),g
opt,k+1 |Lm = lm, Am = am, X
0(k),g
opt,k+1 (ψ∗) = x
]
−E
[
Y
0(k),g
opt,k+1 |Lm = lm, Am = am, X
0(k),g
opt,k+1 = x
]
Above ω
(
a (t) , a (t− 1) , l (t) , ψ
)
and γm
(
a (m) , a (m− 1) , l (m) , ψ
)
are known
functions γm
[
a (k) , a (m− 1) , l (m) , x, β
]
satisfying ω
(
a (t) , a (t− 1) , l (t) , ψ
)
=
0 if a (t) = 0 or ψ = 0 and γm
(
a (m) , a (m− 1) , l (m) , β
)
= 0 if a (m) = 0 or
β = 0.
Recall the optimal regime itself remains unknown. However we show below
that the following algorithm evaluated at the true (β∗, ψ∗) would find the op-
timal regime gopt under the following additional condition, we we henceforth
assume to hold.
Additional Condition : For each a (m− 1) , l (m) , x, β,m the function
γoptm
[
a (k) , a (m− 1) , l (m) , x, β
]
is either everywhere zero or is strictly concave
in a(k) on the support of A (k) .
Optimal Regime Algorithm:
Given any (β, ψ) , calculate gopt,(β,ψ) =
{
gopt(β,ψ),m
[
a (m) , l (m))
]
;m = K, ..., 0
}
as follows.
Calculate X
0(K),g
opt,K+1 (ψ) . Define
g∗opt(β,ψ),K
[
A (K − 1) , L (K))
]
= I (X ≤ K) argmax
a(K)
[
γK
{
a(K), A (K − 1) , L (K) , X, β
}]
+ I (X > K)×
argmax
a(K)
E
[
γK
{
a (K) , A (K − 1) , L (K) , X
0(K),g
opt,K+1 (ψ) , β
}
|A (K − 1) , L (K) , X > k
]
Calculate gopt(β,ψ),K
[
A (K − 1) , L (K))
]
= min
{
A (K) , g∗opt(β,ψ),K
[
A (K − 1) , L (K))
]}
Calculate X
g
opt(β,ψ),K (ψ) = X
gopt(β,ψ),K[A(K),L(K)],g
opt,K+1 (ψ) .
Recursively for m = K − 1, ..., 0, calculate
X
0(m),g
opt,m+1
(β,ψ)
(ψ) ,
g∗opt(β,ψ),m
[
A (m− 1) , L (m))
]
= I (X ≤ m) argmax
a(m)
E
[
γm
{
a (m) , A (m− 1) , L (m) , X, β
}]
+ I (X > m)×
argmax
a(m)
E
[
γm
{
a (m) , A (m− 1) , L (m) , X
0(m),g
opt(β,ψ),m+1 (ψ) , β
}
|A (m− 1) , L (m) , X > m
]
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Calculate gopt(β,ψ),m
[
A (m) , L (m))
]
= min
{
A (m) , g∗opt(β,ψ),m
[
A (m− 1) , L (m))
]}
.
Calculate X
g
opt(β,ψ),m (ψ) = X
gopt(β,ψ),m[A(m),L(m))],gopt,m+1 (ψ)
Note to carry out this algorithm we will need to be able to estimate
E
[
γm
{
a (m) , A (m− 1) , L (m) , X
0(m),g
opt(β,ψ),m+1 (ψ) , β
}
|A (m− 1) , L (m) , X > m
]
for all possible values of a (m) in the support of A (m) . One possibility is to spec-
ify and fit an appropriate multivariate regression model with the possible values
of a (m) indexing the multivariate outcomes at time m.
To understand why this is the correct algorithm, we first note that any regime
atm can be a function ofX only if X ≤ m, so thatX is known bym.When X >
m, we must average over X
0(m),g
opt(β,ψ),m+1 (ψ) because X
0(m),g
opt(β,ψ),m+1 (ψ)
is a function of X. When X > m, X
a(m),g
opt(β,ψ),m+1 (ψ) will be the value of
X
g
opt(β,ψ),m (ψ) if the regime gopt(β,ψ) dictates the exposure a (m) . The optimal
regime will choose the a (m) that optimizes the contribution to the utility at
time m. But the optimizing a (m) depends on the a (k) chosen for the regime
for k > m. Thus we need to use backward recursion to estimate the optimal
regime.
To be more specific consider the subgroup of subjects with a history(
A (K − 1) , L (K) , X
)
with X < K so X = X
0(K),g
opt,K+1 (ψ∗) ∈ L (K) . Then
a (K) = g∗opt(β,ψ),K
[
A (K − 1) , L (K))
]
that maximizes
γK
{
a(K), A (K − 1) , L (K) , X, β∗
}
is clearly the optimal treatment choice at
K. However, we are only considering regimes (interventions) that do not force
subjects to gain weight. We now argue that for any subject with A (K) less than
g∗opt(β,ψ),K
[
A (K − 1) , L (K))
]
, the optimal decison is not to intervene at all,
so the subject receives his observed treatment A (K). The subject with A (K)
less than g∗opt(β,ψ),K
[
A (K − 1) , L (K))
]
could still have received any treatment
between 0 and A (K) . However among this set of treatments, the treatment
A (K) is optimal by Condition a) above.
Next consider the subgroup of subjects with a history
(
A (K − 1) , L (K) , X
)
with X > K so X /∈ L (K) and X
0(K),g
opt,K+1 (ψ∗) > K. To find the op-
timal treatment we average over X
0(K),g
opt,K+1 (ψ∗). Since the average over
X
0(K),g
opt,K+1 (ψ∗) of a function that is concave in a (K) for every possible
value of X
0(K),g
opt,K+1 (ψ∗) remains a concave function of a (K) , we again take
gopt(β,ψ),K
[
A (K − 1) , L (K))
]
= min
{
A (K) , g∗opt(β,ψ),K
[
A (K − 1) , L (K))
]}
.
That the same argument holds for each m is a standard dynamic program-
ming argument as discussed in Robins (2004).
Since (β∗, ψ∗) are unknown we must estimate them by g-estimation. Define
X
gopt(β,ψ)
m (ψ) = X
g
opt,m (ψ)
Y
gopt(β,ψ)
m (β, ψ) = Y −
K∑
m
γm
[
A(m), A (m− 1) , L (m) , X
gopt(β,ψ)
m (ψ) , β
]
.
Note these equations are much more complex than the equations for ψ using
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a SNFTM and SNMM for a fixed g in that gopt is now not known but depends
on the parameters (β, ψ) through the above algorithm for gopt,(β,ψ). Thus we can
no longer estimate ψ∗ independently of β∗ since X
gopt(β,ψ)
m (ψ) is now a function
of β as well as ψ through its dependence on gopt(β,ψ). Rather, we must solve
both pairs of g-estimation equations simultaneously.
Specifically, given the optimal regime RC and CD assumptions, to obtain
CAN estimators of the unknown parameters, we find jointly
(
β˜, ψ˜
)
so that both
the score test for the covariate vector depending on X
gopt(β,ψ)
m (ψ) is precisely
zero and the score test for the covariate vector depending on Y
gopt(β,ψ)
m (β, ψ)
is precisely zero (both tests restricted to subjects with X
gopt(β,ψ)
m (ψ) > ζ and
Ξ (m) = 1.) This turns out to be a very difficult computational problem. Robins
(4) describes a number of computational simplifications, but they are beyond
the scope of the current paper. Finally we obtain gopt(eβ, eψ) as our estimate of
the optimal regime gopt(β∗,ψ∗) and n
−1
∑n
i Y
g
opt( eβ, eψ)
0
[(
β˜, ψ˜
)]
as our estimate
of the expected utility E
[
Y
gopt
0
]
under the optimal regime.
Both estimation of E [Y g0 ] for a known g and of E
[
Y
gopt
0
]
can be modified
to allow for censoring at end of follow-up at K + 1 and for intactable unmea-
sured confounding in certain subgroups using methods exactly analogous to the
methods for estimation of E [Y0].
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